https://www.medxy.ai/news/ultraprocessed-foods-colorectal-risk 2025-11-13T23:32:51.000Z daily 0.75 https://www.medxy.ai/news/zh/glp-1-receptor-agents-analysis 2025-11-13T23:46:29.000Z daily 0.75 https://www.medxy.ai/news/vi/ultra-processed-foods-risk-early-rectal-tumors-women 2025-11-13T23:47:00.000Z daily 0.75 https://www.medxy.ai/news/zh/high-ultra-processed-foods-colon-adenoma-risk 2025-11-13T23:47:29.000Z daily 0.75 https://www.medxy.ai/news/metformin-cardiac-surgery-mortality 2025-11-13T23:48:10.000Z daily 0.75 https://www.medxy.ai/news/vi/metformin-exposure-mortality-reduction 2025-11-14T13:28:53.000Z daily 0.75 https://www.medxy.ai/news/ja/metformin-exposure-mortality-rate 2025-11-13T23:53:36.000Z daily 0.75 https://www.medxy.ai/news/zh/metformin-reduces-mortality 2025-11-13T23:55:26.000Z daily 0.75 https://www.medxy.ai/news/sexual-assault-body-risk 2025-11-14T08:40:22.000Z daily 0.75 https://www.medxy.ai/news/vi/sexual-abuse-body-shadow 2025-11-14T08:45:54.000Z daily 0.75 https://www.medxy.ai/news/ja/sexual-abuse-long-term-effects 2025-11-14T08:48:56.000Z daily 0.75 https://www.medxy.ai/news/intimacy-oxytocin-wound-healing 2025-11-14T08:47:23.000Z daily 0.75 https://www.medxy.ai/news/zh/sexual-assault-long-term-effects 2025-11-14T08:49:46.000Z daily 0.75 https://www.medxy.ai/news/vi/oxytocin-nasal-relationship-recovery 2025-11-14T09:44:02.000Z daily 0.75 https://www.medxy.ai/news/ja/intimacy-oxytocin-healing 2025-11-14T09:44:23.000Z daily 0.75 https://www.medxy.ai/news/zh/intimacy-oxytocin-healing-2 2025-11-14T09:44:16.000Z daily 0.75 https://www.medxy.ai/news/risk-profiles-suicide 2025-11-14T09:05:35.000Z daily 0.75 https://www.medxy.ai/news/vi/suicide-risk-profiles-danish-data 2025-11-14T09:44:32.000Z daily 0.75 https://www.medxy.ai/news/ja/suicide-risk-profiles 2025-11-14T09:44:48.000Z daily 0.75 https://www.medxy.ai/news/zh/suicide-risk-factors-2 2025-11-14T09:44:41.000Z daily 0.75 https://www.medxy.ai/news/cognitive-therapy-suicide-prevention 2025-11-14T09:26:17.000Z daily 0.75 https://www.medxy.ai/news/vi/short-term-cbt-suicide-risk 2025-11-14T09:45:05.000Z daily 0.75 https://www.medxy.ai/news/ja/cbt-suicide-prevention 2025-11-14T09:45:11.000Z daily 0.75 https://www.medxy.ai/news/zh/cognitive-behavioral-therapy-reduces-suicide-attempts 2025-11-14T09:45:19.000Z daily 0.75 https://www.medxy.ai/news/hiit-cannabis-craving 2025-11-14T09:48:04.000Z daily 0.75 https://www.medxy.ai/news/vi/high-intensity-training-among-adults 2025-11-14T09:45:40.000Z daily 0.75 https://www.medxy.ai/news/ja/high-intensity-interval-training-cannabis-use-disorder 2025-11-14T09:48:26.000Z daily 0.75 https://www.medxy.ai/news/ank3-liafensine-depression 2025-11-14T09:45:55.000Z daily 0.75 https://www.medxy.ai/news/zh/high-intensity-training-cannabis-use 2025-11-14T09:48:46.000Z daily 0.75 https://www.medxy.ai/news/vi/liafensine-ank3-clinical-benefits 2025-11-14T10:03:17.000Z daily 0.75 https://www.medxy.ai/news/ja/ank3-liafensine-depression-results 2025-11-14T10:03:09.000Z daily 0.75 https://www.medxy.ai/news/zh/ank3-guided-lifinorden-importance 2025-11-14T10:01:20.000Z daily 0.75 https://www.medxy.ai/news/collaborative-care-oud 2025-11-14T09:59:40.000Z daily 0.75 https://www.medxy.ai/news/vi/collaborative-care-opioid-disorder 2025-11-14T10:08:34.000Z daily 0.75 https://www.medxy.ai/news/ja/primary-care-oud-collaborative-care 2025-11-14T10:08:48.000Z daily 0.75 https://www.medxy.ai/news/zh/collaborative-care-opioid-reduction 2025-11-14T10:13:32.000Z daily 0.75 https://www.medxy.ai/news/quadpill-vs-dual-therapy 2025-11-14T10:19:40.000Z daily 0.75 https://www.medxy.ai/news/zh/quartet-consensus 2025-11-14T10:15:25.000Z daily 0.75 https://www.medxy.ai/news/vi/quartet-therapy-insights 2025-11-14T10:19:23.000Z daily 0.75 https://www.medxy.ai/news/ja/quadpill-or-dual-therapy 2025-11-14T10:19:03.000Z daily 0.75 https://www.medxy.ai/news/ganlum-antimalarial-cure 2025-11-14T10:20:06.000Z daily 0.75 https://www.medxy.ai/news/vi/new-malaria-drug 2025-11-14T10:21:55.000Z daily 0.75 https://www.medxy.ai/news/zh/klu156-clinical-trial-results 2025-11-14T10:27:02.000Z daily 0.75 https://www.medxy.ai/news/unlocking-longevity-sleep-health 2025-11-14T10:26:22.000Z daily 0.75 https://www.medxy.ai/news/vi/sleep-and-health 2025-11-14T12:22:40.000Z daily 0.75 https://www.medxy.ai/news/ja/longevity-sleep-science 2025-11-14T12:23:10.000Z daily 0.75 https://www.medxy.ai/news/rna-cancer-vaccines-2029 2025-11-14T12:28:48.000Z daily 0.75 https://www.medxy.ai/news/zh/rna-cancer-vaccine-2029 2025-11-14T13:20:46.000Z daily 0.75 https://www.medxy.ai/news/ja/rna-cancer-vaccine-advancements 2025-11-14T13:20:52.000Z daily 0.75 https://www.medxy.ai/news/stopping-smoking-recovery 2025-11-14T12:52:35.000Z daily 0.75 https://www.medxy.ai/news/vi/smoking-cessation-and-recovery 2025-11-14T13:21:05.000Z daily 0.75 https://www.medxy.ai/news/ja/smoking-cessation-recovery-2 2025-11-14T13:21:21.000Z daily 0.75 https://www.medxy.ai/news/zh/smoking-cessation-recovery 2025-11-14T13:21:32.000Z daily 0.75 https://www.medxy.ai/news/laparoscopic-gastrectomy-t4a-cancer 2025-11-14T13:12:40.000Z daily 0.75 https://www.medxy.ai/news/vi/laparoscopic-gastrectomy-effectiveness 2025-11-14T13:21:53.000Z daily 0.75 https://www.medxy.ai/news/ja/laparoscopic-gastrectomy-t4a-results 2025-11-14T13:24:30.000Z daily 0.75 https://www.medxy.ai/news/zh/laparoscopic-vs-open-gastrectomy 2025-11-14T13:24:42.000Z daily 0.75 https://www.medxy.ai/news/apixaban-subclinical-afib-bleeds 2025-11-14T13:24:54.000Z daily 0.75 https://www.medxy.ai/news/vi/apixaban-rung-nhi-tiem-an 2025-11-14T13:29:14.000Z daily 0.75 https://www.medxy.ai/news/ja/apixaban-subclinical-af-abdomen-bleeding 2025-11-14T13:34:49.000Z daily 0.75 https://www.medxy.ai/news/zh/apixaban-subclinical-afib 2025-11-14T13:34:41.000Z daily 0.75 https://www.medxy.ai/news/preoperative-hba1c-risk 2025-11-14T13:35:25.000Z daily 0.75 https://www.medxy.ai/news/vi/hba1c-preoperative-risk 2025-11-14T13:46:01.000Z daily 0.75 https://www.medxy.ai/news/ja/preop-hba1c-hidden-risks 2025-11-14T13:45:53.000Z daily 0.75 https://www.medxy.ai/news/zh/preoperative-hba1c-risk-2 2025-11-14T13:45:36.000Z daily 0.75 https://www.medxy.ai/news/personalized-prehabilitation 2025-11-14T16:02:24.000Z daily 0.75 https://www.medxy.ai/news/vi/personalized-surgical-preparation-immunome 2025-11-14T19:48:14.000Z daily 0.75 https://www.medxy.ai/news/ja/pre-surgery-rehabilitation 2025-11-14T19:48:22.000Z daily 0.75 https://www.medxy.ai/news/zh/prehab-immunity-signal 2025-11-14T19:48:29.000Z daily 0.75 https://www.medxy.ai/news/myocardial-infarction-epilepsy-risks 2025-11-14T19:59:06.000Z daily 0.75 https://www.medxy.ai/news/vi/chest-pain-seizures-elderly 2025-11-14T19:59:18.000Z daily 0.75 https://www.medxy.ai/news/ja/myocardial-infarction-epilepsy-elderly 2025-11-14T20:05:50.000Z daily 0.75 https://www.medxy.ai/news/zh/myocardial-infarction-epilepsy-risk 2025-11-14T20:06:07.000Z daily 0.75 https://www.medxy.ai/news/vi/apoe4-dementia-alzheimer-epilepsy 2025-11-14T20:14:44.000Z daily 0.75 https://www.medxy.ai/news/ja/apoe4-early-dementia-epilepsy-2 2025-11-14T20:14:57.000Z daily 0.75 https://www.medxy.ai/news/zh/apoe4-early-dementia-epilepsy 2025-11-14T20:15:09.000Z daily 0.75 https://www.medxy.ai/news/bird-flu-risks 2025-11-14T20:20:20.000Z daily 0.75 https://www.medxy.ai/news/pemvidutide-liver-fat-reduction 2025-11-14T20:26:06.000Z daily 0.75 https://www.medxy.ai/news/vi/pemvidutide-fats-reduction-ai 2025-11-14T20:25:58.000Z daily 0.75 https://www.medxy.ai/news/ja/pemvidutide-liver-fat-reduction-2 2025-11-14T20:32:51.000Z daily 0.75 https://www.medxy.ai/news/h3n2-variant-2025 2025-11-14T20:32:29.000Z daily 0.75 https://www.medxy.ai/news/vi/h3n2-variant-rise-2025-26 2025-11-14T20:33:11.000Z daily 0.75 https://www.medxy.ai/news/zh/pemvidutide-liver-fat-fibrosis 2025-11-14T20:33:31.000Z daily 0.75 https://www.medxy.ai/news/ja/h3n2-variant-awareness 2025-11-14T20:41:04.000Z daily 0.75 https://www.medxy.ai/news/zh/h3n2-variant-2025-26 2025-11-14T20:41:32.000Z daily 0.75 https://www.medxy.ai/news/allogeneic-hct-aya-all-cr2 2025-11-14T20:41:15.000Z daily 0.75 https://www.medxy.ai/news/vi/allogenic-hdca-graft-aya-all 2025-11-15T19:26:01.000Z daily 0.75 https://www.medxy.ai/news/ja/aya-all-hct-outcomes 2025-11-14T20:42:03.000Z daily 0.75 https://www.medxy.ai/news/zh/allogeneic-stem-cell-transplantation 2025-11-14T20:42:32.000Z daily 0.75 https://www.medxy.ai/news/dago2-vs-cpx-351-aml 2025-11-14T20:45:19.000Z daily 0.75 https://www.medxy.ai/news/vi/dago2-versus-cpx-351-among-older-adults 2025-11-15T19:25:38.000Z daily 0.75 https://www.medxy.ai/news/ja/dago2-vs-cpx-351-aml-2 2025-11-14T23:23:14.000Z daily 0.75 https://www.medxy.ai/news/long-term-outcomes-ttp 2025-11-14T23:23:10.000Z daily 0.75 https://www.medxy.ai/news/zh/dago2-among-elderly-aml-patients 2025-11-14T23:23:18.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-results-ttp-therapy 2025-11-14T23:23:22.000Z daily 0.75 https://www.medxy.ai/news/ja/long-term-outcome-ttp 2025-11-14T23:23:26.000Z daily 0.75 https://www.medxy.ai/news/zh/long-term-outlook-cttp 2025-11-14T23:23:30.000Z daily 0.75 https://www.medxy.ai/news/venetoclax-obinutuzumab-cll-efficacy 2025-11-14T23:30:08.000Z daily 0.75 https://www.medxy.ai/news/vi/venetoclax-obinutuzumab-cll-treatment 2025-11-15T19:26:53.000Z daily 0.75 https://www.medxy.ai/news/ja/first-line-cll-treatment 2025-11-15T19:27:24.000Z daily 0.75 https://www.medxy.ai/news/zh/venetoclax-obinutuzumab-ccl-treatment 2025-11-15T19:28:41.000Z daily 0.75 https://www.medxy.ai/news/venetoclax-gilteritinib-flt3-leukemia 2025-11-15T18:24:54.000Z daily 0.75 https://www.medxy.ai/news/vi/venetoclax-gilteritinib-flt3 2025-11-15T19:24:30.000Z daily 0.75 https://www.medxy.ai/news/ja/benetoclax-gilteritinib-leukemia-effect 2025-11-15T19:24:39.000Z daily 0.75 https://www.medxy.ai/news/zh/venetoclax-gilteritinib-leukemia-activity 2025-11-15T19:24:45.000Z daily 0.75 https://www.medxy.ai/news/vi/bcma-mrna-vaccine 2025-11-15T19:35:08.000Z daily 0.75 https://www.medxy.ai/news/ja/bcma-mrna-vaccine-2 2025-11-15T19:35:01.000Z daily 0.75 https://www.medxy.ai/news/zh/bcma-mrna-vaccine-challenges 2025-11-15T19:34:50.000Z daily 0.75 https://www.medxy.ai/news/dago2-vs-cpx351-aml 2025-11-15T19:31:31.000Z daily 0.75 https://www.medxy.ai/news/vi/dag02-vs-cpx351-aml 2025-12-31T23:01:26.000Z daily 0.75 https://www.medxy.ai/news/ja/dago2-aml-insights 2025-12-31T23:02:08.000Z daily 0.75 https://www.medxy.ai/news/zh/dag02-in-elderly-aml 2025-11-15T19:39:15.000Z daily 0.75 https://www.medxy.ai/news/power-of-persistence-exercise-cancer-risk 2025-11-17T09:51:42.000Z daily 0.75 https://www.medxy.ai/news/venetoclax-bcl2-implications 2025-11-17T10:55:57.000Z daily 0.75 https://www.medxy.ai/news/vi/venetoclax-dosing-cll-resistance 2025-12-18T21:06:01.000Z daily 0.75 https://www.medxy.ai/news/ja/benetoclax-dose-increase-cll-impact 2025-11-17T11:53:27.000Z daily 0.75 https://www.medxy.ai/news/zh/vinetoclax-dosing-chronic-lymphocytic-leukemia 2025-11-17T11:53:33.000Z daily 0.75 https://www.medxy.ai/news/age-adapted-chemotherapy-all 2025-11-17T11:24:49.000Z daily 0.75 https://www.medxy.ai/news/vi/age-based-chemotherapy-all-trial-results 2025-11-17T11:53:46.000Z daily 0.75 https://www.medxy.ai/news/ja/age-adaptive-chemo-transplant 2025-11-17T11:53:54.000Z daily 0.75 https://www.medxy.ai/news/zh/age-adaptive-chemotherapy 2025-11-17T11:54:03.000Z daily 0.75 https://www.medxy.ai/news/allo-hsct-pediatric-gimema 2025-11-17T11:37:29.000Z daily 0.75 https://www.medxy.ai/news/vi/allohsct-mrd-outcomes 2025-11-17T11:54:11.000Z daily 0.75 https://www.medxy.ai/news/ja/allohsct-ph-all-mrd-status 2025-11-17T11:54:27.000Z daily 0.75 https://www.medxy.ai/news/zh/gimema-lal1913-all-transplant 2025-11-17T11:54:38.000Z daily 0.75 https://www.medxy.ai/news/cpx-351-down-syndrome-leukemia 2025-11-17T11:48:28.000Z daily 0.75 https://www.medxy.ai/news/vi/cpx-351-down-syndrome-leukemia-2 2025-11-17T11:54:50.000Z daily 0.75 https://www.medxy.ai/news/ja/cpx-351-ds-leukemia 2025-11-17T11:55:05.000Z daily 0.75 https://www.medxy.ai/news/zh/cpx-351-tds-leukemia 2025-11-17T12:10:02.000Z daily 0.75 https://www.medxy.ai/news/metformin-reduces-weight-gain 2025-11-17T12:05:18.000Z daily 0.75 https://www.medxy.ai/news/vi/metformin-weight-loss-children 2025-11-17T12:10:24.000Z daily 0.75 https://www.medxy.ai/news/ja/metformin-weight-gain-bipolar-youth 2025-11-17T12:17:46.000Z daily 0.75 https://www.medxy.ai/news/zh/metformin-reduces-weight-gain-2 2025-11-17T12:18:25.000Z daily 0.75 https://www.medxy.ai/news/tirzepatide-insulin-type-2-diabetes 2025-11-17T12:17:36.000Z daily 0.75 https://www.medxy.ai/news/vi/tirzepatide-insulin-safety-efficacy 2025-11-17T12:56:53.000Z daily 0.75 https://www.medxy.ai/news/ja/tirzepatide-insulin-study 2025-11-17T12:56:44.000Z daily 0.75 https://www.medxy.ai/news/sglt2-inhibitors-fibrosis-masld 2025-11-17T12:56:19.000Z daily 0.75 https://www.medxy.ai/news/vi/sglt2-vs-dpp4-masld 2025-11-17T13:01:43.000Z daily 0.75 https://www.medxy.ai/news/ja/sglt2-vs-dpp4-masld-fibrosis 2025-11-17T13:33:36.000Z daily 0.75 https://www.medxy.ai/news/ai-body-composition-nsclc-2 2025-11-17T13:18:03.000Z daily 0.75 https://www.medxy.ai/news/zh/sglt2-vs-dpp4-fibrosis-risk 2025-11-17T13:18:16.000Z daily 0.75 https://www.medxy.ai/news/vi/body-composition-ai-analysis 2025-11-17T13:18:30.000Z daily 0.75 https://www.medxy.ai/news/ja/ai-body-composition-analysis 2025-11-17T13:18:45.000Z daily 0.75 https://www.medxy.ai/news/zh/ai-body-composition-nsclc 2025-11-17T13:18:54.000Z daily 0.75 https://www.medxy.ai/news/stepped-care-diabetes-cuts 2025-11-17T13:19:01.000Z daily 0.75 https://www.medxy.ai/news/vi/diabetes-care-steps 2025-11-17T13:19:10.000Z daily 0.75 https://www.medxy.ai/news/ja/step-care-cash-incentives 2025-11-17T13:25:30.000Z daily 0.75 https://www.medxy.ai/news/zh/layered-care-cash-incentives-diabetes 2025-11-17T13:25:14.000Z daily 0.75 https://www.medxy.ai/news/metformin-reduces-weight-gain-3 2025-11-17T13:27:33.000Z daily 0.75 https://www.medxy.ai/news/vi/metformin-weight-loss-children-2 2025-11-17T13:28:34.000Z daily 0.75 https://www.medxy.ai/news/ja/metformin-bipolar-weight-gain 2025-11-17T13:28:43.000Z daily 0.75 https://www.medxy.ai/news/zh/metformin-reduces-weight-gain-4 2025-11-17T13:31:21.000Z daily 0.75 https://www.medxy.ai/news/liraglutide-metformin-pcos-benefits 2025-11-17T13:28:59.000Z daily 0.75 https://www.medxy.ai/news/vi/liraglutide-metformin-pcos 2025-11-17T13:57:17.000Z daily 0.75 https://www.medxy.ai/news/ja/pcos-weight-loss-study 2025-11-17T13:57:25.000Z daily 0.75 https://www.medxy.ai/news/zh/liraglutide-metformin-pcos-benefits-2 2025-11-17T13:57:32.000Z daily 0.75 https://www.medxy.ai/news/chiglitazar-metformin-t2dm-results 2025-11-17T13:52:17.000Z daily 0.75 https://www.medxy.ai/news/vi/chiglitazar-metformin-t2dm-results-2 2025-11-17T13:57:38.000Z daily 0.75 https://www.medxy.ai/news/ja/chaglitazar-and-metformin 2025-11-17T15:23:02.000Z daily 0.75 https://www.medxy.ai/news/zh/ziglistat-metaformin-type2-diabetes 2025-11-17T15:23:15.000Z daily 0.75 https://www.medxy.ai/news/type-3c-diabetes 2025-11-17T15:06:31.000Z daily 0.75 https://www.medxy.ai/news/vi/diabetes-type-3c-pancreatitis 2025-11-17T15:23:27.000Z daily 0.75 https://www.medxy.ai/news/ja/chronic-pancreatitis-type-3c-diabetes 2025-11-17T15:23:45.000Z daily 0.75 https://www.medxy.ai/news/zh/chronic-pancreatitis-3c-diabetes 2025-11-17T15:23:56.000Z daily 0.75 https://www.medxy.ai/news/third-agents-metformin 2025-11-17T15:25:40.000Z daily 0.75 https://www.medxy.ai/news/vi/empagliflozin-pioglitazone-glimepiride-hba1c 2025-11-17T15:33:13.000Z daily 0.75 https://www.medxy.ai/news/ja/metformin-dpp4-additions 2025-11-17T15:33:20.000Z daily 0.75 https://www.medxy.ai/news/zh/drug-combination-hba1c 2025-11-17T15:35:17.000Z daily 0.75 https://www.medxy.ai/news/metformin-adverse-effects-adt 2025-11-17T15:33:34.000Z daily 0.75 https://www.medxy.ai/news/vi/metformin-androgen-syndrome-results 2025-11-17T15:42:17.000Z daily 0.75 https://www.medxy.ai/news/metformin-prostate-cancer 2025-11-17T15:42:33.000Z daily 0.75 https://www.medxy.ai/news/ja/metformin-adt-study-results 2025-11-17T15:46:55.000Z daily 0.75 https://www.medxy.ai/news/vi/metformin-prostate-cancer-2 2025-11-17T15:46:42.000Z daily 0.75 https://www.medxy.ai/news/zh/metformin-prime-iii-results 2025-11-17T15:46:30.000Z daily 0.75 https://www.medxy.ai/news/ja/metformin-androgen-deprivation-prostate-cancer 2025-11-17T15:47:35.000Z daily 0.75 https://www.medxy.ai/news/zh/metastatic-prostate-cancer-metformin 2025-11-17T15:59:18.000Z daily 0.75 https://www.medxy.ai/news/reduced-arsenic-water-cancer-mortality 2025-11-17T15:48:36.000Z daily 0.75 https://www.medxy.ai/news/vi/arsenic-reduction-health-benefits-2 2025-11-17T15:59:30.000Z daily 0.75 https://www.medxy.ai/news/ja/arsenic-in-drinking-water-reduction 2025-11-17T15:59:39.000Z daily 0.75 https://www.medxy.ai/news/zh/arsenic-reduction-health-benefits 2025-11-17T15:59:50.000Z daily 0.75 https://www.medxy.ai/news/antibiotics-and-biologic-survival 2025-11-17T16:00:00.000Z daily 0.75 https://www.medxy.ai/news/vi/antibiotic-exposure-persistence-pns 2025-11-17T16:03:55.000Z daily 0.75 https://www.medxy.ai/news/ja/antibiotic-exposure-psoriasis-treatment 2025-11-17T16:06:38.000Z daily 0.75 https://www.medxy.ai/news/zh/antibiotic-exposure-psoriasis-biologics 2025-11-17T16:11:50.000Z daily 0.75 https://www.medxy.ai/news/seborrheic-dermatitis-barrier-pathogenesis 2025-11-17T16:12:26.000Z daily 0.75 https://www.medxy.ai/news/vi/seborrheic-dermatitis-epithelial-barrier 2025-11-17T16:19:56.000Z daily 0.75 https://www.medxy.ai/news/ja/seborrheic-dermatitis-study 2025-11-17T16:20:06.000Z daily 0.75 https://www.medxy.ai/news/fully-human-car-t-remissions 2025-11-17T16:19:43.000Z daily 0.75 https://www.medxy.ai/news/zh/seborrheic-dermatitis-epidermal-barrier 2025-11-17T16:22:15.000Z daily 0.75 https://www.medxy.ai/news/vi/fully-human-car-t-response 2025-11-17T16:23:07.000Z daily 0.75 https://www.medxy.ai/news/zh/gprc5d-car-t-myeloma 2025-11-17T16:29:20.000Z daily 0.75 https://www.medxy.ai/news/metformin-vitamin-b12-effects 2025-11-17T16:31:02.000Z daily 0.75 https://www.medxy.ai/news/vi/metformin-vitamin-b12-impact 2025-11-17T16:45:38.000Z daily 0.75 https://www.medxy.ai/news/ja/metformin-b12-deficiency 2025-11-17T16:45:29.000Z daily 0.75 https://www.medxy.ai/news/zh/metformin-vitamin-b12-levels 2025-11-17T16:45:16.000Z daily 0.75 https://www.medxy.ai/news/preconception-metformin-hyperemesis 2025-11-17T17:23:23.000Z daily 0.75 https://www.medxy.ai/news/vi/metformin-hyperemesis-gravidarum 2025-11-17T17:22:52.000Z daily 0.75 https://www.medxy.ai/news/ja/metformin-pregnancy-nausea-2 2025-11-17T17:22:33.000Z daily 0.75 https://www.medxy.ai/news/zh/metformin-pregnancy-nausea 2025-11-17T17:22:21.000Z daily 0.75 https://www.medxy.ai/news/vi/b-cell-malignancies-cd22 2025-11-17T17:24:20.000Z daily 0.75 https://www.medxy.ai/news/ja/cd22-targeted-tcr 2025-11-17T17:24:43.000Z daily 0.75 https://www.medxy.ai/news/ramantamig-tcell-engager 2025-11-17T17:17:13.000Z daily 0.75 https://www.medxy.ai/news/zh/tcr-vs-car-t-cd22-cancer 2025-11-17T17:25:35.000Z daily 0.75 https://www.medxy.ai/news/vi/ramantamig-jmj-79635322 2025-11-17T17:25:43.000Z daily 0.75 https://www.medxy.ai/news/ja/ramantamig-preclinical-efficacy 2025-11-17T17:25:53.000Z daily 0.75 https://www.medxy.ai/news/zh/ramantamig-trispecific-tcell-agent 2025-11-17T17:31:03.000Z daily 0.75 https://www.medxy.ai/news/modernizing-aml-enrollment 2025-11-17T17:26:09.000Z daily 0.75 https://www.medxy.ai/news/vi/modernizing-aml-participation-criteria 2025-11-17T17:31:14.000Z daily 0.75 https://www.medxy.ai/news/ja/modern-aml-criteria-enhancement 2025-11-17T19:32:23.000Z daily 0.75 https://www.medxy.ai/news/zh/modern-aml-standards-boost-registration 2025-11-17T19:32:32.000Z daily 0.75 https://www.medxy.ai/news/community-health-workers-sickle-cell 2025-11-17T19:29:53.000Z daily 0.75 https://www.medxy.ai/news/vi/community-health-workers-boost-quality-of-life 2025-11-17T19:35:23.000Z daily 0.75 https://www.medxy.ai/news/zh/community-health-workers-sickle-cell-transition 2025-11-17T20:19:31.000Z daily 0.75 https://www.medxy.ai/news/boosting-sleep-apnea-diagnosis 2025-11-17T19:42:47.000Z daily 0.75 https://www.medxy.ai/news/vanishing-female-advantage-ckd 2025-11-17T23:41:35.000Z daily 0.75 https://www.medxy.ai/news/vi/women-survival-disadvantage-kidney-disease 2025-11-18T11:21:39.000Z daily 0.75 https://www.medxy.ai/news/ja/stage-5-ckd-female-survival-advantage 2025-11-18T11:23:12.000Z daily 0.75 https://www.medxy.ai/news/zh/disappearance-of-female-survival-advantage-in-chronic-kidney-disease 2025-11-18T11:24:16.000Z daily 0.75 https://www.medxy.ai/news/ai-screening-triples-detection 2025-11-18T08:01:50.000Z daily 0.75 https://www.medxy.ai/news/vi/ai-filter-boosts-amd-detection 2025-11-18T11:24:24.000Z daily 0.75 https://www.medxy.ai/news/ja/ai-screening-transthyretin-amiloidosis 2025-11-18T11:24:55.000Z daily 0.75 https://www.medxy.ai/news/zh/ai-screening-amyloidosis 2025-11-18T11:25:08.000Z daily 0.75 https://www.medxy.ai/news/boosting-mammogram-rates 2025-11-18T08:49:06.000Z daily 0.75 https://www.medxy.ai/news/long-covid-cognitive-trial 2025-11-18T11:27:16.000Z daily 0.75 https://www.medxy.ai/news/vi/remote-cognitive-training 2025-11-18T11:30:25.000Z daily 0.75 https://www.medxy.ai/news/ja/remote-cognition-training-results 2025-11-18T11:30:48.000Z daily 0.75 https://www.medxy.ai/news/zh/remote-cognition-training 2025-11-18T11:31:36.000Z daily 0.75 https://www.medxy.ai/news/acoramidis-benefit-transthyretin-ameloidosis 2025-11-18T10:27:41.000Z daily 0.75 https://www.medxy.ai/news/vi/acoramidis-benefits-amiodarone 2025-11-18T11:31:48.000Z daily 0.75 https://www.medxy.ai/news/ja/acoramidis-transthyretin-amiloidosis 2025-11-18T11:33:14.000Z daily 0.75 https://www.medxy.ai/news/zh/akramidis-amyloid-benefit 2025-11-18T11:33:49.000Z daily 0.75 https://www.medxy.ai/news/community-health-workers-hemodialysis 2025-11-18T10:46:39.000Z daily 0.75 https://www.medxy.ai/news/vi/community-health-workers-weight-loss-hispanic-kidney 2025-11-18T11:34:00.000Z daily 0.75 https://www.medxy.ai/news/ja/community-health-worker-dialysis 2025-11-18T11:34:31.000Z daily 0.75 https://www.medxy.ai/news/zh/community-health-workers-dialysis-weight-management 2025-11-18T11:35:03.000Z daily 0.75 https://www.medxy.ai/news/short-program-long-gains 2025-11-18T11:37:16.000Z daily 0.75 https://www.medxy.ai/news/vi/short-program-long-benefits 2025-11-18T11:37:02.000Z daily 0.75 https://www.medxy.ai/news/ja/short-program-long-term-benefits 2025-11-18T11:36:52.000Z daily 0.75 https://www.medxy.ai/news/zh/short-term-plan-long-term-gains 2025-11-18T11:36:44.000Z daily 0.75 https://www.medxy.ai/news/uneven-progress-cancer-disparities 2025-11-18T11:37:25.000Z daily 0.75 https://www.medxy.ai/news/vi/uneven-progress-cancer-burden 2025-11-18T11:47:14.000Z daily 0.75 https://www.medxy.ai/news/ja/uneven-progress-cancer-1990-2021 2025-11-18T11:47:32.000Z daily 0.75 https://www.medxy.ai/news/zh/uneven-progress-cns-cancer 2025-11-18T11:47:45.000Z daily 0.75 https://www.medxy.ai/news/mobile-health-vs-transitions-heart-failure 2025-11-18T12:00:38.000Z daily 0.75 https://www.medxy.ai/news/hormone-therapy-hot-flashes 2025-11-18T12:04:12.000Z daily 0.75 https://www.medxy.ai/news/vi/hormone-therapy-hot-flashes-2 2025-11-18T12:08:33.000Z daily 0.75 https://www.medxy.ai/news/ja/hormonal-therapy-hot-flashes 2025-11-18T12:32:43.000Z daily 0.75 https://www.medxy.ai/news/zh/hormone-therapy-hot-flashes-3 2025-11-18T12:32:29.000Z daily 0.75 https://www.medxy.ai/news/host-countries-access-medicines 2025-11-18T12:33:31.000Z daily 0.75 https://www.medxy.ai/news/vi/host-countries-lack-access-to-drugs 2025-11-19T15:24:07.000Z daily 0.75 https://www.medxy.ai/news/ja/timely-access-to-drugs 2025-11-19T15:24:18.000Z daily 0.75 https://www.medxy.ai/news/zh/failed-drug-access-analysis 2025-11-19T15:24:30.000Z daily 0.75 https://www.medxy.ai/news/neural-networks-survival-prediction 2025-11-18T13:33:28.000Z daily 0.75 https://www.medxy.ai/news/vi/neural-network-survival-prediction 2025-11-19T15:24:43.000Z daily 0.75 https://www.medxy.ai/news/ja/neural-network-head-neck-cancer-survival-2 2025-11-19T15:24:59.000Z daily 0.75 https://www.medxy.ai/news/zh/neural-network-head-neck-cancer-survival 2025-11-19T15:25:07.000Z daily 0.75 https://www.medxy.ai/news/preoperative-ct-missing 2025-11-19T15:26:28.000Z daily 0.75 https://www.medxy.ai/news/vi/medicare-payment-gaps 2025-11-19T15:26:08.000Z daily 0.75 https://www.medxy.ai/news/ja/preoperative-ct-gap 2025-11-19T15:25:53.000Z daily 0.75 https://www.medxy.ai/news/zh/preoperative-ct-gaps 2025-11-19T15:25:44.000Z daily 0.75 https://www.medxy.ai/news/preoperative-ct-compliance 2025-11-19T15:27:05.000Z daily 0.75 https://www.medxy.ai/news/vi/ct-scan-preoperative-compliance-2 2025-11-19T15:27:15.000Z daily 0.75 https://www.medxy.ai/news/ja/preoperative-nasal-balloon-ct 2025-11-19T15:27:44.000Z daily 0.75 https://www.medxy.ai/news/zh/preoperative-ct-ballon-sinus-dilation 2025-11-19T15:27:58.000Z daily 0.75 https://www.medxy.ai/news/deep-learning-otolaryngology 2025-11-19T15:23:21.000Z daily 0.75 https://www.medxy.ai/news/vi/deep-learning-ent-otolaryngology 2025-11-19T15:28:12.000Z daily 0.75 https://www.medxy.ai/news/ja/deep-learning-in-ent 2025-11-19T16:05:43.000Z daily 0.75 https://www.medxy.ai/news/zh/deep-learning-ent-otolaryngology-2 2025-11-19T16:05:54.000Z daily 0.75 https://www.medxy.ai/news/preoperative-ablative-radiotherapy 2025-11-19T15:32:40.000Z daily 0.75 https://www.medxy.ai/news/vi/radiation-therapy-breast-cancer 2025-11-19T16:06:10.000Z daily 0.75 https://www.medxy.ai/news/ja/early-hr-breast-cancer-ablation 2025-11-19T16:06:45.000Z daily 0.75 https://www.medxy.ai/news/zh/early-hr-positive-breast-cancer-ablative-therapy 2025-11-19T16:07:08.000Z daily 0.75 https://www.medxy.ai/news/therapist-guided-ehealth-cuts-cancer-fear 2025-11-19T16:07:27.000Z daily 0.75 https://www.medxy.ai/news/vi/e-health-therapy-colon-cancer-fear 2025-11-19T20:07:10.000Z daily 0.75 https://www.medxy.ai/news/ja/ehealth-colorectal-cancer-recovery 2025-11-19T20:07:36.000Z daily 0.75 https://www.medxy.ai/news/zh/therapist-led-ehealth-intervention 2025-11-19T20:07:49.000Z daily 0.75 https://www.medxy.ai/news/antibody-drug-conjugates-heart-risk 2025-11-19T20:08:01.000Z daily 0.75 https://www.medxy.ai/news/vi/antibody-drug-combinations-breast-cancer 2025-11-19T20:08:08.000Z daily 0.75 https://www.medxy.ai/news/ja/her2-positive-breast-cancer-risk 2025-11-19T20:08:26.000Z daily 0.75 https://www.medxy.ai/news/zh/her2-breast-cancer-risks 2025-11-19T20:08:36.000Z daily 0.75 https://www.medxy.ai/news/proton-beam-vs-imrt 2025-11-19T18:53:53.000Z daily 0.75 https://www.medxy.ai/news/vi/proton-vs-imrt-olfactory-tumors 2025-11-19T20:08:50.000Z daily 0.75 https://www.medxy.ai/news/ja/proton-therapy-olfactory-neuroblastoma 2025-11-19T20:09:04.000Z daily 0.75 https://www.medxy.ai/news/zh/proton-beam-therapy-osm-nerve-tumors 2025-11-19T20:09:20.000Z daily 0.75 https://www.medxy.ai/news/weight-trajectories-youths 2025-11-19T19:04:31.000Z daily 0.75 https://www.medxy.ai/news/vi/teen-weight-paths-moves 2025-11-19T20:09:34.000Z daily 0.75 https://www.medxy.ai/news/ja/young-people-weight-change-after-relocation 2025-11-19T20:09:50.000Z daily 0.75 https://www.medxy.ai/news/temporary-hemodialysis-access 2025-11-19T20:06:24.000Z daily 0.75 https://www.medxy.ai/news/vi/temporary-access-blood-filter 2025-11-19T20:12:55.000Z daily 0.75 https://www.medxy.ai/news/ja/temporary-dialysis-access 2025-11-19T22:52:53.000Z daily 0.75 https://www.medxy.ai/news/zh/no-insurance-patients-temporary-dialysis 2025-11-19T22:53:03.000Z daily 0.75 https://www.medxy.ai/news/intervention-lowers-hemorrhage-risk 2025-11-19T20:21:21.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-bleeding-risk-intervention-avm 2025-11-19T22:53:23.000Z daily 0.75 https://www.medxy.ai/news/ja/intervention-reducing-bleeding-risk 2025-11-19T22:53:39.000Z daily 0.75 https://www.medxy.ai/news/zh/intervention-reduces-hemorrhage-risk 2025-11-19T22:53:50.000Z daily 0.75 https://www.medxy.ai/news/vi/female-sex-and-sepsis-mortality 2025-11-19T22:55:49.000Z daily 0.75 https://www.medxy.ai/news/ja/female-gender-and-gram-negative-bacteremia 2025-11-19T22:57:16.000Z daily 0.75 https://www.medxy.ai/news/zh/female-gender-and-bacterial-sepsis-mortality 2025-11-19T22:57:58.000Z daily 0.75 https://www.medxy.ai/news/acute-kidney-injury-risk 2025-11-19T20:50:38.000Z daily 0.75 https://www.medxy.ai/news/vi/acute-kidney-injury-in-preterm-infants-2 2025-11-21T10:07:54.000Z daily 0.75 https://www.medxy.ai/news/ja/acute-kidney-injury-in-preterm-infants 2025-11-21T10:08:22.000Z daily 0.75 https://www.medxy.ai/news/zh/premature-kidney-injury-risks 2025-11-21T10:08:38.000Z daily 0.75 https://www.medxy.ai/news/general-practice-follow-up 2025-11-19T21:57:05.000Z daily 0.75 https://www.medxy.ai/news/vi/monitoring-tracheostomy-children 2025-11-21T10:08:53.000Z daily 0.75 https://www.medxy.ai/news/ja/pediatric-tracheal-tube-observation 2025-11-21T10:48:56.000Z daily 0.75 https://www.medxy.ai/news/zh/pediatric-airway-management 2025-11-21T10:09:21.000Z daily 0.75 https://www.medxy.ai/news/palliative-care-head-neck-cancer-2 2025-11-21T10:09:38.000Z daily 0.75 https://www.medxy.ai/news/vi/palliative-care-head-neck-cancer-3 2025-11-21T10:09:47.000Z daily 0.75 https://www.medxy.ai/news/ja/palliative-care-head-and-neck-cancer 2025-11-21T10:10:04.000Z daily 0.75 https://www.medxy.ai/news/zh/palliative-care-head-neck-cancer-4 2025-11-21T10:10:14.000Z daily 0.75 https://www.medxy.ai/news/palliative-care-head-neck-cancer 2025-11-19T22:51:24.000Z daily 0.75 https://www.medxy.ai/news/adenotonsillectomy-vs-watchful-waiting 2025-11-20T07:49:12.000Z daily 0.75 https://www.medxy.ai/news/vi/tonsil-surgery-vs-watchful-waiting 2025-11-21T10:13:52.000Z daily 0.75 https://www.medxy.ai/news/ja/tonsillectomy-observation-results 2025-11-21T10:14:08.000Z daily 0.75 https://www.medxy.ai/news/zh/adenotonsillectomy-vs-observation 2025-11-21T10:14:18.000Z daily 0.75 https://www.medxy.ai/news/radiotherapy-vestibular-schwannomas 2025-11-20T17:01:25.000Z daily 0.75 https://www.medxy.ai/news/vi/radiotherapy-for-vestibular-chondroma 2025-11-21T10:14:29.000Z daily 0.75 https://www.medxy.ai/news/ja/radiation-treatment-for-schwannoma 2025-11-21T10:14:55.000Z daily 0.75 https://www.medxy.ai/news/zh/radiation-therapy-vestibular-schwaanoma 2025-11-21T10:15:29.000Z daily 0.75 https://www.medxy.ai/news/adenotonsillectomy-lowers-blood-pressure 2025-11-20T17:09:47.000Z daily 0.75 https://www.medxy.ai/news/vi/tonsil-surgery-benefits-obese-kids 2025-11-21T10:15:41.000Z daily 0.75 https://www.medxy.ai/news/ja/tonsillectomy-sleep-apnea 2025-11-21T10:16:08.000Z daily 0.75 https://www.medxy.ai/news/zh/adenotonsillectomy-sleep-apnea 2025-11-21T10:16:44.000Z daily 0.75 https://www.medxy.ai/news/pathologic-response-nivolumab-hpv-negative 2025-11-21T09:48:18.000Z daily 0.75 https://www.medxy.ai/news/vi/nivolumab-hpv-cancer-survival 2025-11-21T10:16:58.000Z daily 0.75 https://www.medxy.ai/news/ja/neoadjuvant-nivolumab-response 2025-11-21T10:17:12.000Z daily 0.75 https://www.medxy.ai/news/zh/hpv-negative-head-neck-cancer-survival 2025-11-21T10:04:58.000Z daily 0.75 https://www.medxy.ai/news/proton-vs-imrt-olfactory-neuroblastoma 2025-11-21T10:01:32.000Z daily 0.75 https://www.medxy.ai/news/vi/tia-cuc-tim-imrt-u-than-kinh 2025-11-21T10:48:23.000Z daily 0.75 https://www.medxy.ai/news/ja/proton-therapy-vs-imrt 2025-11-21T10:17:50.000Z daily 0.75 https://www.medxy.ai/news/zh/proton-therapy-olfactory-neuroblastoma-2 2025-11-21T10:18:07.000Z daily 0.75 https://www.medxy.ai/news/unilateral-tors-hpv-tonsil-cancer 2025-11-21T10:44:57.000Z daily 0.75 https://www.medxy.ai/news/vi/robotic-oropharyngeal-surgery-hpv 2025-11-21T10:46:35.000Z daily 0.75 https://www.medxy.ai/news/ja/tors-safety-hpv-cancer 2025-11-21T10:47:02.000Z daily 0.75 https://www.medxy.ai/news/zh/single-side-robotic-tonsil-surgery 2025-11-21T10:43:58.000Z daily 0.75 https://www.medxy.ai/news/pfizer-mrna-flu-vaccine-efficacy-2 2025-11-21T10:41:51.000Z daily 0.75 https://www.medxy.ai/news/vi/pfizer-tetravalent-mrna-vaccine-efficacy 2025-11-21T10:43:27.000Z daily 0.75 https://www.medxy.ai/news/ja/pfizer-mrna-flu-vaccine 2025-11-21T10:43:41.000Z daily 0.75 https://www.medxy.ai/news/zh/pfizer-mrna-flu-vaccine-efficacy 2025-11-21T10:49:25.000Z daily 0.75 https://www.medxy.ai/news/doublet-chemo-egfr-braf-survival 2025-11-21T10:50:54.000Z daily 0.75 https://www.medxy.ai/news/vi/double-target-therapy-egfr-braf 2025-11-21T11:05:01.000Z daily 0.75 https://www.medxy.ai/news/ja/double-regimen-cancer-therapy 2025-11-21T11:05:20.000Z daily 0.75 https://www.medxy.ai/news/zh/dual-therapy-efficacy 2025-11-21T11:05:34.000Z daily 0.75 https://www.medxy.ai/news/hpv-positive-oropharyngeal-cancer-survival 2025-11-21T11:08:20.000Z daily 0.75 https://www.medxy.ai/news/vi/hpv-positive-throat-cancer-survival 2025-11-21T11:33:09.000Z daily 0.75 https://www.medxy.ai/news/ja/hpv-positive-oropharyngeal-cancer-survival-2 2025-11-21T11:34:20.000Z daily 0.75 https://www.medxy.ai/news/zh/hpv-positive-oropharyngeal-cancer-over-70 2025-11-21T11:34:29.000Z daily 0.75 https://www.medxy.ai/news/adjuvant-chemoradiotherapy-oral-scc 2025-11-21T11:23:33.000Z daily 0.75 https://www.medxy.ai/news/vi/radiotherapy-support-large-nodal-expansion-hnc 2025-11-21T11:34:39.000Z daily 0.75 https://www.medxy.ai/news/ja/radiation-therapy-benefits 2025-11-21T11:35:01.000Z daily 0.75 https://www.medxy.ai/news/zh/radiotherapy-pharyngeal-cancer-lymph-nodes 2025-11-21T11:35:16.000Z daily 0.75 https://www.medxy.ai/news/basal-calcitonin-cutoffs 2025-11-21T11:31:09.000Z daily 0.75 https://www.medxy.ai/news/vi/calcitonin-thresholds-lymph-node-metastasis 2025-11-21T16:13:44.000Z daily 0.75 https://www.medxy.ai/news/ja/updated-calcitonin-thresholds-2 2025-11-21T16:16:57.000Z daily 0.75 https://www.medxy.ai/news/zh/updated-calcitonin-thresholds 2025-11-21T16:14:09.000Z daily 0.75 https://www.medxy.ai/news/crest-2-stenting-stroke-reduction 2025-11-21T13:19:37.000Z daily 0.75 https://www.medxy.ai/news/vi/crest-2-carotid-stenosis-stroke-risk 2025-11-21T16:17:08.000Z daily 0.75 https://www.medxy.ai/news/ja/crest-2-stent-treatment 2025-11-21T16:17:18.000Z daily 0.75 https://www.medxy.ai/news/zh/crest-2-stenting-vs-medication 2025-11-21T16:17:30.000Z daily 0.75 https://www.medxy.ai/news/intracoronary-stem-cells-heart-failure 2025-11-21T13:29:02.000Z daily 0.75 https://www.medxy.ai/news/vi/whartons-gest-therapy-heart-failure 2025-11-21T16:17:40.000Z daily 0.75 https://www.medxy.ai/news/ja/acute-st-elevation-myocardial-infarction-cells-2 2025-11-21T16:21:52.000Z daily 0.75 https://www.medxy.ai/news/zh/acute-st-elevation-myocardial-infarction-cells 2025-11-21T16:18:29.000Z daily 0.75 https://www.medxy.ai/news/vernakalant-vs-procainamide 2025-11-21T16:01:33.000Z daily 0.75 https://www.medxy.ai/news/vi/vernakalant-vs-procainamide-2 2025-11-21T16:24:14.000Z daily 0.75 https://www.medxy.ai/news/ja/raff4-results-ventricular-fibrillation 2025-11-21T16:24:41.000Z daily 0.75 https://www.medxy.ai/news/zh/vernakalant-vs-procainamide-3 2025-11-21T16:24:55.000Z daily 0.75 https://www.medxy.ai/news/expect-it-decision-tool 2025-11-21T16:25:06.000Z daily 0.75 https://www.medxy.ai/news/vi/expect-it-tool 2025-11-21T17:08:12.000Z daily 0.75 https://www.medxy.ai/news/ja/expect-it-decision-tool-2 2025-11-21T17:08:44.000Z daily 0.75 https://www.medxy.ai/news/zh/expect-it-decision-tool-3 2025-11-21T17:09:00.000Z daily 0.75 https://www.medxy.ai/news/myocardial-injury-head-neck-surgery 2025-11-21T17:09:16.000Z daily 0.75 https://www.medxy.ai/news/vi/common-myocardial-injury 2025-11-21T17:13:40.000Z daily 0.75 https://www.medxy.ai/news/ja/cardiac-injury-after-surgery 2025-11-22T21:31:51.000Z daily 0.75 https://www.medxy.ai/news/zh/cardiac-injury-post-surgery 2025-11-22T21:32:04.000Z daily 0.75 https://www.medxy.ai/news/hnc-8d-utility-measure 2025-11-21T17:30:49.000Z daily 0.75 https://www.medxy.ai/news/vi/hnc-8d-head-neck-cancer-health 2025-11-22T21:32:15.000Z daily 0.75 https://www.medxy.ai/news/ja/hnc-8d-health-status-improvement 2025-11-22T21:32:30.000Z daily 0.75 https://www.medxy.ai/news/zh/hnc-8d-health-outcomes 2025-11-22T21:32:41.000Z daily 0.75 https://www.medxy.ai/news/multisystem-mortality-risks-cyclones 2025-11-21T17:57:45.000Z daily 0.75 https://www.medxy.ai/news/vi/tropical-storm-risk-assessment 2025-11-22T21:33:17.000Z daily 0.75 https://www.medxy.ai/news/ja/unequal-death-risks-post-typhoon 2025-11-22T21:33:34.000Z daily 0.75 https://www.medxy.ai/news/zh/post-cyclone-inequality-risks 2025-11-22T21:33:43.000Z daily 0.75 https://www.medxy.ai/news/urban-greenness-mental-health 2025-11-22T13:37:29.000Z daily 0.75 https://www.medxy.ai/news/vi/green-urban-levels-mental-health 2025-11-22T21:33:52.000Z daily 0.75 https://www.medxy.ai/news/ja/urban-greening-mental-health-2 2025-11-22T21:34:01.000Z daily 0.75 https://www.medxy.ai/news/zh/urban-greening-mental-health 2025-11-22T21:34:11.000Z daily 0.75 https://www.medxy.ai/news/clinical-benefit-not-billing 2025-11-22T18:35:03.000Z daily 0.75 https://www.medxy.ai/news/vi/clinical-benefits-medical-decisions 2025-11-22T21:34:26.000Z daily 0.75 https://www.medxy.ai/news/ja/clinical-benefit-drives-oncologist-decisions 2025-11-22T21:34:37.000Z daily 0.75 https://www.medxy.ai/news/zh/clinical-benefits-over-profit 2025-11-22T21:34:46.000Z daily 0.75 https://www.medxy.ai/news/basal-calcitonin-cutoffs-2 2025-11-23T15:08:06.000Z daily 0.75 https://www.medxy.ai/news/vi/calcitonin-thresholds-thyroid-cancer 2025-11-22T21:34:56.000Z daily 0.75 https://www.medxy.ai/news/ja/updated-calcitonin-thresholds-3 2025-11-22T21:35:12.000Z daily 0.75 https://www.medxy.ai/news/zh/updated-calcitonin-thresholds-4 2025-11-22T21:35:36.000Z daily 0.75 https://www.medxy.ai/news/preoperative-predictors-adjuvant-therapy 2025-11-22T21:35:26.000Z daily 0.75 https://www.medxy.ai/news/vi/pre-surgery-signs-cancer 2025-11-22T21:35:56.000Z daily 0.75 https://www.medxy.ai/news/ja/oral-cancer-surgery-prediction 2025-11-22T23:34:12.000Z daily 0.75 https://www.medxy.ai/news/zh/preoperative-predictors-oral-cancer 2025-11-22T21:36:29.000Z daily 0.75 https://www.medxy.ai/news/oral-anticoagulant-therapy 2025-11-22T23:33:03.000Z daily 0.75 https://www.medxy.ai/news/vi/continue-vs-stop-anticoagulation 2025-11-22T23:33:07.000Z daily 0.75 https://www.medxy.ai/news/ja/persistent-anticoagulation-comparison 2025-11-22T23:33:14.000Z daily 0.75 https://www.medxy.ai/news/zh/no-reason-vte-treatment 2025-11-22T23:33:23.000Z daily 0.75 https://www.medxy.ai/news/maternal-paracetamol-neurodevelopment 2025-11-22T23:31:23.000Z daily 0.75 https://www.medxy.ai/news/vi/paracetamol-thai-ky-em 2025-11-22T23:37:12.000Z daily 0.75 https://www.medxy.ai/news/ja/maternal-paracetamol-child-neurodevelopment 2025-11-22T23:49:03.000Z daily 0.75 https://www.medxy.ai/news/zh/acetaminophen-pregnancy-child-development 2025-11-22T23:49:15.000Z daily 0.75 https://www.medxy.ai/news/continuing-anticoagulation-vte 2025-11-22T23:55:30.000Z daily 0.75 https://www.medxy.ai/news/vi/continuing-anticoagulation-vte-2 2025-11-23T08:13:42.000Z daily 0.75 https://www.medxy.ai/news/ja/vte-anticoagulation-therapy-results 2025-11-23T08:13:56.000Z daily 0.75 https://www.medxy.ai/news/zh/anticoagulation-vte-outcomes 2025-11-23T08:14:04.000Z daily 0.75 https://www.medxy.ai/news/metformin-ferroptosis-aml 2025-11-23T00:12:24.000Z daily 0.75 https://www.medxy.ai/news/vi/metformin-ferroptosis-aml-2 2025-11-23T09:17:55.000Z daily 0.75 https://www.medxy.ai/news/ja/metformin-induces-ferroptosis-aml 2025-11-23T09:18:04.000Z daily 0.75 https://www.medxy.ai/news/zh/metabolic-opportunities-in-leukemia 2025-11-23T09:18:10.000Z daily 0.75 https://www.medxy.ai/news/metformin-obesity-prostate-cancer 2025-11-23T08:13:31.000Z daily 0.75 https://www.medxy.ai/news/vi/metformin-prostate-cancer-obesity 2025-11-23T09:18:30.000Z daily 0.75 https://www.medxy.ai/news/ja/metformin-prostate-cancer-risk 2025-11-23T09:18:46.000Z daily 0.75 https://www.medxy.ai/news/zh/metformin-prostate-cancer-signal 2025-11-23T09:18:56.000Z daily 0.75 https://www.medxy.ai/news/glp1-receptor-agonsits-fibrosis-masld-t2dm 2025-11-23T09:22:51.000Z daily 0.75 https://www.medxy.ai/news/vi/glp-1-agonsits-fibrosis-masld-t2dm 2025-11-23T09:59:25.000Z daily 0.75 https://www.medxy.ai/news/ja/glp-1-fibrosis-inhibition 2025-11-23T09:59:35.000Z daily 0.75 https://www.medxy.ai/news/zh/glp-1-receptor-agonists-fibrosis 2025-11-23T09:59:43.000Z daily 0.75 https://www.medxy.ai/news/metformin-fails-low-risk-prostate-cancer 2025-11-23T09:54:51.000Z daily 0.75 https://www.medxy.ai/news/vi/metformin-prostate-cancer-risk-2 2025-11-23T09:59:58.000Z daily 0.75 https://www.medxy.ai/news/ja/metformin-prostate-cancer-signals 2025-11-23T10:00:19.000Z daily 0.75 https://www.medxy.ai/news/zh/metformin-prostate-cancer-signals-2 2025-11-23T10:10:37.000Z daily 0.75 https://www.medxy.ai/news/idsa-2025-flu-rsv-recommendations 2025-11-23T10:07:43.000Z daily 0.75 https://www.medxy.ai/news/zh/idsa-2025-influenza-rsv-vaccine-guidelines 2025-11-23T10:11:07.000Z daily 0.75 https://www.medxy.ai/news/vi/idsa-2025-vaccine-recommendations 2025-11-23T10:14:20.000Z daily 0.75 https://www.medxy.ai/news/ja/idsa-2025-flu-rsv-vaccine-updates 2025-11-23T14:35:26.000Z daily 0.75 https://www.medxy.ai/news/ibd-boost-review-2 2025-11-23T14:35:56.000Z daily 0.75 https://www.medxy.ai/news/vi/ibd-boost-program-evaluation 2025-11-23T14:36:07.000Z daily 0.75 https://www.medxy.ai/news/zh/ibd-boost-review 2025-11-23T14:36:36.000Z daily 0.75 https://www.medxy.ai/news/wildfire-smoke-pregnancy-risk 2025-11-23T14:33:11.000Z daily 0.75 https://www.medxy.ai/news/vi/wildfire-smoke-premature-birth 2025-11-23T14:40:29.000Z daily 0.75 https://www.medxy.ai/news/ja/smoke-pregnancy-risk 2025-11-23T14:40:14.000Z daily 0.75 https://www.medxy.ai/news/zh/wildfire-smoke-pregnancy-risk-2 2025-11-23T14:46:53.000Z daily 0.75 https://www.medxy.ai/news/peer-self-harm-risk 2025-11-23T14:47:45.000Z daily 0.75 https://www.medxy.ai/news/vi/friends-self-harm-risk-teens 2025-11-23T14:47:02.000Z daily 0.75 https://www.medxy.ai/news/ja/self-harm-risk-puberty 2025-11-23T14:47:24.000Z daily 0.75 https://www.medxy.ai/news/zh/self-harm-risk-peaks-16 2025-11-23T14:47:35.000Z daily 0.75 https://www.medxy.ai/news/brand-specific-flu-vaccine-effectiveness 2025-11-23T14:52:31.000Z daily 0.75 https://www.medxy.ai/news/vi/efficacy-of-flu-vaccines-seniors 2025-11-23T14:59:54.000Z daily 0.75 https://www.medxy.ai/news/ja/nordic-elderly-flu-vaccine-effect 2025-11-23T15:00:16.000Z daily 0.75 https://www.medxy.ai/news/zh/nordic-vaccine-effectiveness 2025-11-23T15:00:45.000Z daily 0.75 https://www.medxy.ai/news/riv4-influenza-vaccine-results 2025-11-23T15:11:14.000Z daily 0.75 https://www.medxy.ai/news/vi/tetravalent-flu-vaccine-results 2025-11-23T15:16:24.000Z daily 0.75 https://www.medxy.ai/news/riv4-vaccine-safety-efficacy 2025-11-23T15:16:34.000Z daily 0.75 https://www.medxy.ai/news/zh/riv4-vaccine-safety-efficacy-2 2025-11-23T17:54:45.000Z daily 0.75 https://www.medxy.ai/news/mycoplasma-pneumoniae-resurgence 2025-11-23T17:56:42.000Z daily 0.75 https://www.medxy.ai/news/vi/mycoplasma-pneumoniae-outbreak-france 2025-11-23T17:56:46.000Z daily 0.75 https://www.medxy.ai/news/ja/pediatric-mycoplasma-outbreak-france 2025-11-23T17:56:11.000Z daily 0.75 https://www.medxy.ai/news/zh/post-covid-pneumonia-in-children 2025-11-23T17:56:23.000Z daily 0.75 https://www.medxy.ai/news/targeted-vaccination-bangladesh 2025-11-23T18:01:02.000Z daily 0.75 https://www.medxy.ai/news/vi/vaccination-effectiveness-bangladesh 2025-11-23T18:02:06.000Z daily 0.75 https://www.medxy.ai/news/ja/targeted-vaccination-efficiency 2025-11-23T18:02:18.000Z daily 0.75 https://www.medxy.ai/news/zh/cost-effective-japanese-encephalitis 2025-11-23T18:02:33.000Z daily 0.75 https://www.medxy.ai/news/shorter-is-safe 2025-11-23T18:02:59.000Z daily 0.75 https://www.medxy.ai/news/vi/safer-shorter-antibiotic-therapy 2025-11-23T18:06:06.000Z daily 0.75 https://www.medxy.ai/news/zh/shorter-safer-antibiotic-course 2025-11-23T18:10:57.000Z daily 0.75 https://www.medxy.ai/news/single-shot-rvf-trial 2025-11-23T18:11:30.000Z daily 0.75 https://www.medxy.ai/news/vi/single-dose-rift-valley-fever-trial 2025-11-23T19:01:05.000Z daily 0.75 https://www.medxy.ai/news/ja/rough-valley-vaccine-trial 2025-11-23T19:01:23.000Z daily 0.75 https://www.medxy.ai/news/monkeypox-vaccination-insights 2025-11-23T19:01:35.000Z daily 0.75 https://www.medxy.ai/news/zh/chadox1-rvf-vaccine-trial 2025-11-23T19:01:44.000Z daily 0.75 https://www.medxy.ai/news/vi/mpox-vaccine-study-insights 2025-11-23T19:02:09.000Z daily 0.75 https://www.medxy.ai/news/ja/monkeypox-vaccine-clinical-insights 2025-11-23T19:02:21.000Z daily 0.75 https://www.medxy.ai/news/zh/monkeypox-vaccine-study 2025-11-23T19:02:31.000Z daily 0.75 https://www.medxy.ai/news/vla15-booster-responses 2025-11-23T19:03:07.000Z daily 0.75 https://www.medxy.ai/news/vi/vla15-18-month-boost-response 2025-11-23T19:23:31.000Z daily 0.75 https://www.medxy.ai/news/ja/vla15-booster-antibody-response 2025-11-23T19:23:41.000Z daily 0.75 https://www.medxy.ai/news/zh/vla15-vaccine-boost-18-months 2025-11-23T19:24:03.000Z daily 0.75 https://www.medxy.ai/news/marburg-virus-rwanda-2024-2 2025-11-23T19:23:50.000Z daily 0.75 https://www.medxy.ai/news/vi/marburg-virus-rwanda-2024 2025-11-23T19:24:16.000Z daily 0.75 https://www.medxy.ai/news/ja/rwanda-marburg-virus-2024 2025-11-23T19:24:27.000Z daily 0.75 https://www.medxy.ai/news/zh/malaria-in-rwanda-2024 2025-11-23T19:24:44.000Z daily 0.75 https://www.medxy.ai/news/validated-impact-tool 2025-11-23T19:26:02.000Z daily 0.75 https://www.medxy.ai/news/vi/impact-tool-for-outpatient-management 2025-11-23T19:47:16.000Z daily 0.75 https://www.medxy.ai/news/ja/validated-impact-tool-meningioma-risk 2025-11-23T19:47:32.000Z daily 0.75 https://www.medxy.ai/news/zh/verified-impact-tool-management 2025-11-23T19:56:34.000Z daily 0.75 https://www.medxy.ai/news/androgen-deprivation-therapy-duration 2025-11-23T19:36:17.000Z daily 0.75 https://www.medxy.ai/news/vi/androgen-therapy-duration 2025-11-23T19:56:52.000Z daily 0.75 https://www.medxy.ai/news/ja/balance-of-benefit-harm 2025-11-23T19:57:00.000Z daily 0.75 https://www.medxy.ai/news/zh/benefit-risk-balance-prostate-cancer 2025-11-23T19:57:11.000Z daily 0.75 https://www.medxy.ai/news/ensitrelvir-vs-nirmatrelvir 2025-11-23T19:44:20.000Z daily 0.75 https://www.medxy.ai/news/vi/ensitrelvir-nirmatrelvir-sars-cov-2 2025-11-23T20:10:49.000Z daily 0.75 https://www.medxy.ai/news/ja/ensitrelvir-sars-cov-2-removal 2025-11-23T20:11:10.000Z daily 0.75 https://www.medxy.ai/news/zh/enhanced-nirmatrelvir-results 2025-11-23T20:15:28.000Z daily 0.75 https://www.medxy.ai/news/den-core-dengue-trials 2025-11-23T19:58:04.000Z daily 0.75 https://www.medxy.ai/news/zh/den-core-international-consensus-dengue-trial 2025-11-23T20:35:54.000Z daily 0.75 https://www.medxy.ai/news/vi/den-core-clinical-standards 2025-11-23T20:15:44.000Z daily 0.75 https://www.medxy.ai/news/ja/den-core-dengue-trial-agreement 2025-11-23T20:15:51.000Z daily 0.75 https://www.medxy.ai/news/post-covid-condition-measurement 2025-11-23T20:16:33.000Z daily 0.75 https://www.medxy.ai/news/zh/post-covid-symptoms-measurement 2025-11-23T20:34:29.000Z daily 0.75 https://www.medxy.ai/news/vi/covid-19-status-measurement 2025-11-23T20:34:39.000Z daily 0.75 https://www.medxy.ai/news/ja/long-covid-clinical-trials 2025-11-23T20:34:47.000Z daily 0.75 https://www.medxy.ai/news/healthy-aging-recommendations 2025-11-23T20:31:53.000Z daily 0.75 https://www.medxy.ai/news/basic-health-aging-standards 2025-11-23T20:35:41.000Z daily 0.75 https://www.medxy.ai/news/vi/healthy-aging-criteria 2025-11-23T20:45:33.000Z daily 0.75 https://www.medxy.ai/news/ja/standardized-healthy-aging-primacy 2025-11-23T20:50:00.000Z daily 0.75 https://www.medxy.ai/news/human-monoclonal-antibody-mam01 2025-11-23T20:50:18.000Z daily 0.75 https://www.medxy.ai/news/vi/mam01-antibody-malaria 2025-11-23T20:50:28.000Z daily 0.75 https://www.medxy.ai/news/ja/malaria-antibody-development 2025-11-23T20:50:37.000Z daily 0.75 https://www.medxy.ai/news/zh/mam01-malaria-antibody 2025-11-23T20:50:47.000Z daily 0.75 https://www.medxy.ai/news/single-low-dose-primaquine 2025-11-23T20:50:59.000Z daily 0.75 https://www.medxy.ai/news/vi/single-low-dose-primaquine-2 2025-11-23T20:55:16.000Z daily 0.75 https://www.medxy.ai/news/ja/single-dose-plasminin-effectiveness 2025-11-24T07:44:56.000Z daily 0.75 https://www.medxy.ai/news/zh/single-dose-artesunate-safety 2025-11-24T07:44:48.000Z daily 0.75 https://www.medxy.ai/news/zanidatamab-results 2025-11-24T08:01:26.000Z daily 0.75 https://www.medxy.ai/news/vi/zanidatamab-her2-cancer-benefits 2025-11-24T07:58:12.000Z daily 0.75 https://www.medxy.ai/news/ja/zanidatamab-her2-positive-biliary-cancer 2025-11-24T07:58:24.000Z daily 0.75 https://www.medxy.ai/news/zh/zanidatamab-her2-cancer-results 2025-11-24T07:59:20.000Z daily 0.75 https://www.medxy.ai/news/vi/red-wolf-symptoms 2025-11-24T08:09:24.000Z daily 0.75 https://www.medxy.ai/news/ja/lupus-like-syndrome 2025-11-24T08:09:11.000Z daily 0.75 https://www.medxy.ai/news/zh/lupus-myositis-cancer 2025-11-24T08:08:50.000Z daily 0.75 https://www.medxy.ai/news/navepegritide-achondroplasia-trial 2025-11-24T08:08:01.000Z daily 0.75 https://www.medxy.ai/news/vi/navepegritide-weekly-approach 2025-11-24T08:18:05.000Z daily 0.75 https://www.medxy.ai/news/ja/weekly-naberpegledide-results 2025-11-24T09:12:28.000Z daily 0.75 https://www.medxy.ai/news/zh/navepegritide-growth-children 2025-11-24T09:12:21.000Z daily 0.75 https://www.medxy.ai/news/ivermectin-moxidectin-gains 2025-11-24T09:08:49.000Z daily 0.75 https://www.medxy.ai/news/vi/ivermectin-moxidectin-albendazole-trichuris 2025-11-24T10:43:42.000Z daily 0.75 https://www.medxy.ai/news/ja/ivermectin-moxidectin-combination 2025-11-24T10:43:56.000Z daily 0.75 https://www.medxy.ai/news/zh/oral-treatment-improvement 2025-11-24T10:44:03.000Z daily 0.75 https://www.medxy.ai/news/rifasutenizol-vs-bismuth-clarithromycin 2025-11-24T12:10:52.000Z daily 0.75 https://www.medxy.ai/news/vi/rifasutenizol-vs-bismuth-hp-treatment 2025-11-24T12:10:58.000Z daily 0.75 https://www.medxy.ai/news/ja/refastinib-combination-therapy 2025-11-24T12:11:06.000Z daily 0.75 https://www.medxy.ai/news/zh/rifapentine-therapy-h-pylori 2025-11-24T12:11:17.000Z daily 0.75 https://www.medxy.ai/news/clofazimine-rifapentine-tb-study 2025-11-24T11:52:59.000Z daily 0.75 https://www.medxy.ai/news/vi/clofazimine-rifapentine-study 2025-11-24T12:11:29.000Z daily 0.75 https://www.medxy.ai/news/ja/clofazimine-rifapentine-failure 2025-11-24T12:11:38.000Z daily 0.75 https://www.medxy.ai/news/zh/clo-fast-trial-results 2025-11-24T12:11:45.000Z daily 0.75 https://www.medxy.ai/news/voriconazole-vs-itraconazole 2025-11-24T12:08:57.000Z daily 0.75 https://www.medxy.ai/news/vi/voriconazole-vs-itraconazole-2 2025-11-24T12:33:40.000Z daily 0.75 https://www.medxy.ai/news/ja/victor-cpa-exam-itraconaazol-efficacy 2025-11-24T12:33:55.000Z daily 0.75 https://www.medxy.ai/news/zh/voriconazole-vs-itraconazole-3 2025-11-24T12:34:09.000Z daily 0.75 https://www.medxy.ai/news/bivalent-rsv-vaccine-impact 2025-11-24T12:34:18.000Z daily 0.75 https://www.medxy.ai/news/vi/bivalent-rsv-vaccine-impact-2 2025-11-24T13:34:59.000Z daily 0.75 https://www.medxy.ai/news/ja/rsv-vaccine-efficacy 2025-11-24T13:35:15.000Z daily 0.75 https://www.medxy.ai/news/zh/rsv-vaccine-reduces-hospitalizations-2 2025-11-24T13:35:25.000Z daily 0.75 https://www.medxy.ai/news/gestational-weight-gain-outcomes 2025-11-24T12:53:23.000Z daily 0.75 https://www.medxy.ai/news/vi/weight-gain-pregnancy 2025-11-24T13:35:35.000Z daily 0.75 https://www.medxy.ai/news/ja/glp-1-stops-weight-gain 2025-11-24T13:35:43.000Z daily 0.75 https://www.medxy.ai/news/zh/glp-1-therapy-pregnancy-weight-gain 2025-11-24T13:35:54.000Z daily 0.75 https://www.medxy.ai/news/amyloid-pet-risk-mci-dementia 2025-11-24T13:51:58.000Z daily 0.75 https://www.medxy.ai/news/vi/centiloid-pet-amyloid-risk 2025-11-24T13:52:21.000Z daily 0.75 https://www.medxy.ai/news/ja/amyloid-pet-dementia-risk 2025-11-24T13:52:46.000Z daily 0.75 https://www.medxy.ai/news/zh/amyloid-pet-centiloid-risk 2025-11-24T13:53:02.000Z daily 0.75 https://www.medxy.ai/news/higher-risks-after-covid 2025-11-24T13:48:05.000Z daily 0.75 https://www.medxy.ai/news/vi/sars-cov2-vs-vaccine-risks 2025-11-24T14:00:57.000Z daily 0.75 https://www.medxy.ai/news/ja/rare-but-real-vascular-risk 2025-11-24T14:01:13.000Z daily 0.75 https://www.medxy.ai/news/zh/rare-but-real-sars-cov-2-risk 2025-11-24T14:01:28.000Z daily 0.75 https://www.medxy.ai/news/dutch-registry-scc-burden 2025-11-24T14:03:19.000Z daily 0.75 https://www.medxy.ai/news/vi/netherlands-register-healthcare-burden 2025-11-24T14:03:13.000Z daily 0.75 https://www.medxy.ai/news/ja/netherlands-registry-skin-cancer 2025-11-24T14:03:02.000Z daily 0.75 https://www.medxy.ai/news/zh/netherlands-scc-burden-risks 2025-11-24T14:06:50.000Z daily 0.75 https://www.medxy.ai/news/half-of-cancer-survivors-report-unmet-needs 2025-11-24T14:07:09.000Z daily 0.75 https://www.medxy.ai/news/vi/cancer-survivor-support-needs 2025-11-24T14:17:31.000Z daily 0.75 https://www.medxy.ai/news/ja/survivors-support-needs 2025-11-24T14:17:43.000Z daily 0.75 https://www.medxy.ai/news/zh/unmet-support-needs-head-neck-cancer 2025-11-24T14:17:51.000Z daily 0.75 https://www.medxy.ai/news/head-neck-cancer-care-needs 2025-11-24T14:16:11.000Z daily 0.75 https://www.medxy.ai/news/vi/survivor-cancer-care 2025-11-24T14:36:47.000Z daily 0.75 https://www.medxy.ai/news/ja/head-and-neck-cancer-survivors-care-needs 2025-11-24T14:36:58.000Z daily 0.75 https://www.medxy.ai/news/zh/one-third-cancer-survivor-needs 2025-11-24T14:37:06.000Z daily 0.75 https://www.medxy.ai/news/cervarix-vs-gardasil-4 2025-11-24T14:26:50.000Z daily 0.75 https://www.medxy.ai/news/vi/cervarix-vs-gardasil 2025-11-24T14:37:17.000Z daily 0.75 https://www.medxy.ai/news/ja/gardasil-vs-gardasil4 2025-11-24T14:37:26.000Z daily 0.75 https://www.medxy.ai/news/zh/single-dose-sirna-induction-hpv-16 2025-11-24T14:37:37.000Z daily 0.75 https://www.medxy.ai/news/hpv-vaccine-immunogenicity 2025-11-24T14:33:35.000Z daily 0.75 https://www.medxy.ai/news/vi/hpv-vaccine-immune-response 2025-11-24T14:37:50.000Z daily 0.75 https://www.medxy.ai/news/ja/hpv-vaccine-immunogenicity-india 2025-11-24T14:48:31.000Z daily 0.75 https://www.medxy.ai/news/paxg-vs-mfolfirinox-2 2025-11-24T14:48:46.000Z daily 0.75 https://www.medxy.ai/news/vi/paxg-surgery-survival-boost 2025-11-24T14:48:54.000Z daily 0.75 https://www.medxy.ai/news/ja/preoperative-paxg-improves-survival 2025-11-24T14:49:09.000Z daily 0.75 https://www.medxy.ai/news/zh/paxg-vs-mfolfirinox 2025-11-24T14:49:17.000Z daily 0.75 https://www.medxy.ai/news/vi/ai-vs-doctors-panorama 2025-11-24T15:11:05.000Z daily 0.75 https://www.medxy.ai/news/ja/ai-detects-pancreatic-cancer 2025-11-24T15:11:46.000Z daily 0.75 https://www.medxy.ai/news/zh/ai-pancreatic-cancer-detection 2025-11-24T15:12:08.000Z daily 0.75 https://www.medxy.ai/news/prediabetes-pathways 2025-11-24T14:54:12.000Z daily 0.75 https://www.medxy.ai/news/vi/diabetes-money-trail 2025-11-24T15:12:21.000Z daily 0.75 https://www.medxy.ai/news/ja/prediabetes-pathways-2 2025-11-24T15:12:29.000Z daily 0.75 https://www.medxy.ai/news/zh/prediabetes-pathways-3 2025-11-24T15:12:36.000Z daily 0.75 https://www.medxy.ai/news/il-10-anti-cd19-car-t-cells 2025-11-24T15:14:47.000Z daily 0.75 https://www.medxy.ai/news/vi/il-10-car-t-cells-b-all 2025-11-24T15:18:15.000Z daily 0.75 https://www.medxy.ai/news/cirrhosis-incidence-sweden 2025-11-24T15:20:38.000Z daily 0.75 https://www.medxy.ai/news/liver-disease-rates-sweden 2025-11-24T15:20:26.000Z daily 0.75 https://www.medxy.ai/news/ja/il-10-car-t-b-all-treatment 2025-11-24T15:21:42.000Z daily 0.75 https://www.medxy.ai/news/zh/il-10-cd19-car-t-therapy 2025-11-24T15:24:57.000Z daily 0.75 https://www.medxy.ai/news/ja/liver-cirrhosis-incidence-sweden 2025-11-24T15:25:27.000Z daily 0.75 https://www.medxy.ai/news/zh/liver-cirrhosis-epidemiology-sweden 2025-11-24T15:25:38.000Z daily 0.75 https://www.medxy.ai/news/vi/breastfeeding-impact-on-noncommunicable-diseases 2025-11-24T15:37:18.000Z daily 0.75 https://www.medxy.ai/news/ja/breastfeeding-impact-noncommunicable-diseases 2025-11-24T15:38:51.000Z daily 0.75 https://www.medxy.ai/news/aducanumab-cortical-amyloid-aria 2025-11-24T15:37:49.000Z daily 0.75 https://www.medxy.ai/news/vi/aducanumab-amyloid-vascular-damage 2025-11-24T15:47:36.000Z daily 0.75 https://www.medxy.ai/news/ja/aducanumab-amyloid-removal 2025-11-24T15:47:47.000Z daily 0.75 https://www.medxy.ai/news/zh/aducanumab-ameliorates-amyloid 2025-11-24T15:47:59.000Z daily 0.75 https://www.medxy.ai/news/morphine-chronic-breathlessness 2025-11-24T15:47:21.000Z daily 0.75 https://www.medxy.ai/news/vi/morphine-breathing-pain 2025-11-24T19:02:27.000Z daily 0.75 https://www.medxy.ai/news/ja/morphine-does-not-improve-dyspnea 2025-11-24T19:02:40.000Z daily 0.75 https://www.medxy.ai/news/zh/morphine-chronic-breathing-trouble 2025-11-24T19:02:49.000Z daily 0.75 https://www.medxy.ai/news/olorofim-phase-2b-results 2025-11-24T17:44:35.000Z daily 0.75 https://www.medxy.ai/news/vi/olorofim-new-treatment-fungal-infections 2025-11-24T19:02:57.000Z daily 0.75 https://www.medxy.ai/news/ja/olorofim-new-treatment-options 2025-11-24T19:03:11.000Z daily 0.75 https://www.medxy.ai/news/zh/olorofim-antifungal-options 2025-11-24T19:03:27.000Z daily 0.75 https://www.medxy.ai/news/enasidenib-venetoclax-aml-results 2025-11-24T18:58:53.000Z daily 0.75 https://www.medxy.ai/news/vi/enasidenib-venetoclax-amw 2025-11-24T19:03:34.000Z daily 0.75 https://www.medxy.ai/news/ja/enasidenib-benetoclax-aml-results 2025-11-24T20:06:21.000Z daily 0.75 https://www.medxy.ai/news/zh/enavem-aml-idh2 2025-11-24T20:06:14.000Z daily 0.75 https://www.medxy.ai/news/oral-kras-g12d-inhibitor-results 2025-11-24T20:06:07.000Z daily 0.75 https://www.medxy.ai/news/ja/gfh375-kras-g12d-study 2025-11-24T20:05:31.000Z daily 0.75 https://www.medxy.ai/news/zh/krad-g12d-inhibitor-results 2025-11-24T20:03:05.000Z daily 0.75 https://www.medxy.ai/news/adolescent-tumor-survival 2025-11-24T20:07:00.000Z daily 0.75 https://www.medxy.ai/news/zh/young-adult-tumor-survival 2025-11-24T21:21:35.000Z daily 0.75 https://www.medxy.ai/news/neoadjuvant-chidamide-chemotherapy 2025-11-24T23:28:43.000Z daily 0.75 https://www.medxy.ai/news/vi/chidamide-antracycline-taxane-35 2025-11-24T23:39:52.000Z daily 0.75 https://www.medxy.ai/news/zh/rcb-0-i-rate-breast-cancer 2025-11-24T23:40:07.000Z daily 0.75 https://www.medxy.ai/news/china-acute-leukaemia-study 2025-11-24T23:40:31.000Z daily 0.75 https://www.medxy.ai/news/vi/china-leukemia-survival-gap 2025-11-25T08:25:50.000Z daily 0.75 https://www.medxy.ai/news/zh/acute-leukemia-china-burden 2025-11-25T08:26:01.000Z daily 0.75 https://www.medxy.ai/news/severe-radiation-toxicity 2025-11-25T09:23:17.000Z daily 0.75 https://www.medxy.ai/news/vi/radiation-toxicity-cancer 2025-11-25T09:23:08.000Z daily 0.75 https://www.medxy.ai/news/ja/severe-late-radiation-injury-head-neck-cancer 2025-11-25T09:23:31.000Z daily 0.75 https://www.medxy.ai/news/zh/severe-late-stage-reactions 2025-11-25T09:23:45.000Z daily 0.75 https://www.medxy.ai/news/venetoclax-phase-2-study 2025-11-25T08:53:06.000Z daily 0.75 https://www.medxy.ai/news/vi/venetoclax-survival-study 2025-11-25T09:23:56.000Z daily 0.75 https://www.medxy.ai/news/ja/rbac-benetoclax-lymphoma-results 2025-11-25T09:24:04.000Z daily 0.75 https://www.medxy.ai/news/zh/vincristine-rbac-trial-results 2025-11-25T09:24:12.000Z daily 0.75 https://www.medxy.ai/news/breast-cancer-survival-gaps 2025-11-25T09:22:15.000Z daily 0.75 https://www.medxy.ai/news/vi/breast-cancer-mortality-africa 2025-11-25T09:31:24.000Z daily 0.75 https://www.medxy.ai/news/ja/sub-saharan-africa-breast-cancer-mortality 2025-11-25T09:31:35.000Z daily 0.75 https://www.medxy.ai/news/zh/sub-saharan-breast-cancer-mortality 2025-11-25T09:31:44.000Z daily 0.75 https://www.medxy.ai/news/left-atrial-appendage-occlusion 2025-11-25T09:44:17.000Z daily 0.75 https://www.medxy.ai/news/vi/ear-plug-strokes-outcomes 2025-11-25T09:39:48.000Z daily 0.75 https://www.medxy.ai/news/ja/l-aa-closure-and-stroke-outcomes 2025-11-25T09:43:58.000Z daily 0.75 https://www.medxy.ai/news/zh/laaos-iii-study 2025-11-25T09:43:01.000Z daily 0.75 https://www.medxy.ai/news/thyroid-cancer-overdiagnosis 2025-11-25T09:41:33.000Z daily 0.75 https://www.medxy.ai/news/vi/thyroid-cancer-increase 2025-11-25T09:47:56.000Z daily 0.75 https://www.medxy.ai/news/ja/thyroid-cancer-rising 2025-11-25T09:48:45.000Z daily 0.75 https://www.medxy.ai/news/zh/thyroid-cancer-rise 2025-11-25T09:50:53.000Z daily 0.75 https://www.medxy.ai/news/foundation-models-ophthalmology 2025-11-25T09:51:25.000Z daily 0.75 https://www.medxy.ai/news/vi/platform-models-knowledge-gap 2025-11-25T09:51:45.000Z daily 0.75 https://www.medxy.ai/news/ja/basic-models-bridging-knowledge-gap 2025-11-25T09:59:13.000Z daily 0.75 https://www.medxy.ai/news/zh/foundation-model-eye-knowledge-gap 2025-11-25T09:59:08.000Z daily 0.75 https://www.medxy.ai/news/manual-marking-vs-digital-guidance 2025-11-25T10:19:11.000Z daily 0.75 https://www.medxy.ai/news/vi/manual-capsulorhexis-accuracy 2025-11-25T10:19:30.000Z daily 0.75 https://www.medxy.ai/news/ja/manual-marking-cataract-surgery 2025-11-25T10:18:11.000Z daily 0.75 https://www.medxy.ai/news/zh/manual-marking-accuracy 2025-11-25T10:18:04.000Z daily 0.75 https://www.medxy.ai/news/total-pancreatectomy-risk 2025-11-25T10:16:27.000Z daily 0.75 https://www.medxy.ai/news/vi/international-reference-value-pancreatectomy 2025-11-25T10:19:48.000Z daily 0.75 https://www.medxy.ai/news/ja/pancreatectomy-surgical-risks 2025-11-25T10:27:25.000Z daily 0.75 https://www.medxy.ai/news/zh/pancreatectomy-risk-comparison 2025-11-25T10:49:39.000Z daily 0.75 https://www.medxy.ai/news/rising-inhaler-emissions 2025-11-25T10:41:19.000Z daily 0.75 https://www.medxy.ai/news/vi/inhaler-emissions-us 2025-11-25T10:32:44.000Z daily 0.75 https://www.medxy.ai/news/ja/inhaler-emissions-us-2 2025-11-25T10:34:30.000Z daily 0.75 https://www.medxy.ai/news/late-life-epilepsy-clusters 2025-11-25T10:33:36.000Z daily 0.75 https://www.medxy.ai/news/zh/inhaler-emissions-rise 2025-11-25T10:41:42.000Z daily 0.75 https://www.medxy.ai/news/vi/epilepsy-end-of-life-medicare 2025-11-25T10:38:19.000Z daily 0.75 https://www.medxy.ai/news/ja/us-medicare-epilepsy-geography 2025-11-25T10:48:10.000Z daily 0.75 https://www.medxy.ai/news/zh/us-epilepsy-elderly-clusters 2025-11-25T10:48:18.000Z daily 0.75 https://www.medxy.ai/news/guideline-physical-activity-carriers 2025-11-25T10:40:53.000Z daily 0.75 https://www.medxy.ai/news/vi/moderate-to-high-physical-activity-guide 2025-11-25T10:48:28.000Z daily 0.75 https://www.medxy.ai/news/ja/moderate-high-intensity-exercise-safety 2025-11-25T10:48:38.000Z daily 0.75 https://www.medxy.ai/news/zh/recommended-activities-for-cardiomyopathy 2025-11-25T10:49:52.000Z daily 0.75 https://www.medxy.ai/news/atorvastatin-aortic-elasticity 2025-11-25T10:50:10.000Z daily 0.75 https://www.medxy.ai/news/vi/atorvastatin-aortic-protection 2025-11-25T10:59:35.000Z daily 0.75 https://www.medxy.ai/news/ja/atorvastatin-aorta-elasticity 2025-11-25T10:59:50.000Z daily 0.75 https://www.medxy.ai/news/zh/atorvastatin-aortic-elasticity-stop-ca 2025-11-25T11:00:00.000Z daily 0.75 https://www.medxy.ai/news/psychedelics-mdma-mental-disorders 2025-11-25T10:56:12.000Z daily 0.75 https://www.medxy.ai/news/vi/hallucinogens-mdma-mental-disorders 2025-11-25T11:00:32.000Z daily 0.75 https://www.medxy.ai/news/ja/psychedelic-drugs-mdma-effects 2025-11-25T11:03:39.000Z daily 0.75 https://www.medxy.ai/news/cancer-nerves-immunity-strategy 2025-11-25T11:06:17.000Z daily 0.75 https://www.medxy.ai/news/zh/psychedelics-mdma-mental-health 2025-11-25T11:05:38.000Z daily 0.75 https://www.medxy.ai/news/vi/cancer-immune-strategy 2025-11-25T11:07:20.000Z daily 0.75 https://www.medxy.ai/news/ja/cancer-immune-therapy-strategy 2025-11-25T11:08:37.000Z daily 0.75 https://www.medxy.ai/news/antibiotic-prophylaxis-upper-gi-bleeding 2025-11-25T11:08:54.000Z daily 0.75 https://www.medxy.ai/news/zh/cancer-nerve-escape-pathway 2025-11-25T11:19:47.000Z daily 0.75 https://www.medxy.ai/news/vi/antibiotic-prophylaxis-liver-cirrhosis 2025-11-25T11:15:37.000Z daily 0.75 https://www.medxy.ai/news/ja/antibiotic-prophylaxis-gastroduodenal-bleeding 2025-11-25T11:15:26.000Z daily 0.75 https://www.medxy.ai/news/zh/liver-cirrhosis-antibiotic-prevention 2025-11-25T11:19:56.000Z daily 0.75 https://www.medxy.ai/news/invisible-invaders-microplastics-risk 2025-11-25T11:16:42.000Z daily 0.75 https://www.medxy.ai/news/vi/invisible-invaders-plastic-artery-risk 2025-11-25T11:21:55.000Z daily 0.75 https://www.medxy.ai/news/ja/invisible-invaders-microplastics-arteriosclerosis 2025-11-25T11:23:24.000Z daily 0.75 https://www.medxy.ai/news/zh/microplastics-blood-vessel-study 2025-11-25T11:42:38.000Z daily 0.75 https://www.medxy.ai/news/five-year-visual-outcomes 2025-11-25T11:37:58.000Z daily 0.75 https://www.medxy.ai/news/vi/visual-outcomes-pediatric-cataract 2025-11-25T11:42:53.000Z daily 0.75 https://www.medxy.ai/news/ja/pediatric-traumatic-cataract-outcomes 2025-11-25T11:43:29.000Z daily 0.75 https://www.medxy.ai/news/zh/pediatric-cataract-outcomes 2025-11-25T11:48:13.000Z daily 0.75 https://www.medxy.ai/news/hispanic-medicare-hearing-loss 2025-11-25T11:44:36.000Z daily 0.75 https://www.medxy.ai/news/vi/medicare-hearing-loss 2025-11-25T11:48:24.000Z daily 0.75 https://www.medxy.ai/news/ja/hearing-disabilities-medicare-hispanics 2025-11-25T12:17:55.000Z daily 0.75 https://www.medxy.ai/news/zh/hearing-loss-medicare-seniors 2025-11-25T12:18:08.000Z daily 0.75 https://www.medxy.ai/news/rigid-gas-permeable-contact-lenses 2025-11-25T12:01:31.000Z daily 0.75 https://www.medxy.ai/news/vi/clevr-pcg-glaucoma 2025-11-25T12:18:23.000Z daily 0.75 https://www.medxy.ai/news/ja/visual-reconstruction-glaucoma 2025-11-25T12:21:00.000Z daily 0.75 https://www.medxy.ai/news/zh/clevr-pcg-trial-results 2025-11-25T12:21:08.000Z daily 0.75 https://www.medxy.ai/news/food-biodiversity-eat-lancet-2 2025-11-25T12:21:22.000Z daily 0.75 https://www.medxy.ai/news/vi/biodiversity-food-diet 2025-11-25T12:24:20.000Z daily 0.75 https://www.medxy.ai/news/ja/food-biodiversity-eat-lancet 2025-11-25T12:24:11.000Z daily 0.75 https://www.medxy.ai/news/zh/food-diversity-nutrition-insights 2025-11-25T12:24:05.000Z daily 0.75 https://www.medxy.ai/news/biomarker-preventive-care-akihalved 2025-11-25T20:31:14.000Z daily 0.75 https://www.medxy.ai/news/vi/biomarker-based-care-aki-risk 2025-11-25T20:30:48.000Z daily 0.75 https://www.medxy.ai/news/ja/biomarker-preventive-care 2025-11-25T20:30:42.000Z daily 0.75 https://www.medxy.ai/news/zh/biomarker-guided-care 2025-11-25T20:30:33.000Z daily 0.75 https://www.medxy.ai/news/ropeginterferon-vs-anagrelide-2 2025-11-25T20:28:44.000Z daily 0.75 https://www.medxy.ai/news/vi/ropeginterferon-vs-anagrelide 2025-11-25T20:29:02.000Z daily 0.75 https://www.medxy.ai/news/ja/hidroxyurea-resistant-thrombocytosis-treatment 2025-11-25T20:29:17.000Z daily 0.75 https://www.medxy.ai/news/zh/ropeginterferon-alpha-2b-platelet-disorder 2025-11-25T20:29:31.000Z daily 0.75 https://www.medxy.ai/news/plcom2012-vs-nelson-lung-cancer 2025-11-25T20:29:51.000Z daily 0.75 https://www.medxy.ai/news/vi/plcom2012-vs-nelson-lung-cancer-detection 2025-11-25T20:32:14.000Z daily 0.75 https://www.medxy.ai/news/ja/lung-cancer-detection-germany 2025-11-25T20:35:58.000Z daily 0.75 https://www.medxy.ai/news/plcom2012-risk-assessment 2025-11-27T08:32:01.000Z daily 0.75 https://www.medxy.ai/news/hlagenetics-igg4-disease 2025-11-25T20:35:24.000Z daily 0.75 https://www.medxy.ai/news/vi/genetic-factors-igg4-japan 2025-11-26T08:20:49.000Z daily 0.75 https://www.medxy.ai/news/ja/genetic-factors-ig4-disease 2025-11-26T08:20:35.000Z daily 0.75 https://www.medxy.ai/news/zh/hla-fcgr2b-complement-c4 2025-11-26T08:20:18.000Z daily 0.75 https://www.medxy.ai/news/vi/viral-clonality-score-htlv1 2025-11-27T08:18:09.000Z daily 0.75 https://www.medxy.ai/news/vi/uniform-marker-htlv-1-risk 2025-11-27T08:23:20.000Z daily 0.75 https://www.medxy.ai/news/ja/htlv-1-high-risk 2025-11-27T08:30:38.000Z daily 0.75 https://www.medxy.ai/news/zh/viral-clone-uniformity-htlv1 2025-11-27T08:30:26.000Z daily 0.75 https://www.medxy.ai/news/engasertib-recurrent-epistaxis 2025-11-27T08:25:44.000Z daily 0.75 https://www.medxy.ai/news/vi/engasertib-nosebleed-treatment 2025-11-27T08:30:53.000Z daily 0.75 https://www.medxy.ai/news/ja/engaserib-hht-nosebleed 2025-11-27T08:31:36.000Z daily 0.75 https://www.medxy.ai/news/zh/engage-tib-bleeding-disorder 2025-11-27T17:06:16.000Z daily 0.75 https://www.medxy.ai/news/daily-high-dose-mosnodenvir-viremia 2025-11-27T08:32:23.000Z daily 0.75 https://www.medxy.ai/news/vi/mosnodenvir-daily-dose-dengue 2025-11-27T17:06:41.000Z daily 0.75 https://www.medxy.ai/news/ja/daily-mosunotensil-dengue-virus 2025-11-27T17:06:34.000Z daily 0.75 https://www.medxy.ai/news/zh/daily-high-dose-mosunetuzumab-denv-3 2025-11-27T17:06:49.000Z daily 0.75 https://www.medxy.ai/news/engasertib-epistaxis-hht-benefits 2025-11-27T17:05:59.000Z daily 0.75 https://www.medxy.ai/news/vi/engasertib-nasal-bleeding-hht 2025-11-27T17:39:06.000Z daily 0.75 https://www.medxy.ai/news/ja/engaseribib-hht-nosebleed-reduction 2025-11-27T17:39:14.000Z daily 0.75 https://www.medxy.ai/news/zh/engasertib-nosebleed-potential 2025-11-27T17:39:28.000Z daily 0.75 https://www.medxy.ai/news/hidden-burden-metastatic-recurrence 2025-11-27T17:31:28.000Z daily 0.75 https://www.medxy.ai/news/vi/hidden-burden-teen-responses 2025-11-27T17:43:43.000Z daily 0.75 https://www.medxy.ai/news/ja/hidden-burden-teen-survivorship 2025-11-27T17:43:50.000Z daily 0.75 https://www.medxy.ai/news/osteoradionecrosis-risk-proton-therapy 2025-11-27T18:01:48.000Z daily 0.75 https://www.medxy.ai/news/zh/hidden-burden-cancer 2025-11-27T17:43:02.000Z daily 0.75 https://www.medxy.ai/news/vi/osteoradionecrosis-risk-proton-therapy-2 2025-11-27T18:01:05.000Z daily 0.75 https://www.medxy.ai/news/ja/proton-therapy-imrt-osteoradionecrosis 2025-11-27T18:00:56.000Z daily 0.75 https://www.medxy.ai/news/zh/proton-therapy-bone-necrosis-risk 2025-11-27T18:01:17.000Z daily 0.75 https://www.medxy.ai/news/ush1c-usher-syndrome 2025-11-27T18:02:29.000Z daily 0.75 https://www.medxy.ai/news/standardizing-hidradenitis-suppurativa 2025-11-27T18:04:26.000Z daily 0.75 https://www.medxy.ai/news/standardizing-hidradenitis-identification 2025-11-27T17:59:41.000Z daily 0.75 https://www.medxy.ai/news/zh/standardized-research-methods 2025-11-27T18:42:40.000Z daily 0.75 https://www.medxy.ai/news/vi/hidradenitis-suppurativa-criteria 2025-11-27T18:43:10.000Z daily 0.75 https://www.medxy.ai/news/ja/standardization-of-investigators 2025-11-27T18:44:04.000Z daily 0.75 https://www.medxy.ai/news/ja/jak2-gene-fusions-mycodosis 2025-11-27T18:37:20.000Z daily 0.75 https://www.medxy.ai/news/fcrn-blockade-sjogrens-results 2025-11-27T18:42:14.000Z daily 0.75 https://www.medxy.ai/news/vi/nipocalimab-sjogren-study 2025-11-28T09:12:56.000Z daily 0.75 https://www.medxy.ai/news/ja/nipocalimab-fcrn-inhibition-sjogrens 2025-11-28T09:13:06.000Z daily 0.75 https://www.medxy.ai/news/zh/nipocalimab-fcrn-sjogrens 2025-11-28T09:13:23.000Z daily 0.75 https://www.medxy.ai/news/balcinrenone-dapagliflozin-albuminuria 2025-11-28T09:12:41.000Z daily 0.75 https://www.medxy.ai/news/vi/balcinrenone-dapagliflozin-proteinuria 2025-11-28T09:20:06.000Z daily 0.75 https://www.medxy.ai/news/ja/baricitinib-dapagliflozin-ckd 2025-11-28T09:20:17.000Z daily 0.75 https://www.medxy.ai/news/zh/baricitinib-dapagliflozin-proteinuria-reduction 2025-11-28T09:34:52.000Z daily 0.75 https://www.medxy.ai/news/inhaled-methoxyflurane-pain-relief 2025-11-28T09:21:35.000Z daily 0.75 https://www.medxy.ai/news/vi/methoxyflurane-vs-standard-pain-relief 2025-11-28T09:35:01.000Z daily 0.75 https://www.medxy.ai/news/ja/inhaled-methoxyflurane-pain-relief-2 2025-11-28T09:40:03.000Z daily 0.75 https://www.medxy.ai/news/orforglipron-diabetes-obesity 2025-11-28T09:28:57.000Z daily 0.75 https://www.medxy.ai/news/zh/inhaled-methoxyflurane-pain-relief-3 2025-11-28T09:40:14.000Z daily 0.75 https://www.medxy.ai/news/vi/orforglipron-diabetes-obesity-2 2025-11-28T09:40:21.000Z daily 0.75 https://www.medxy.ai/news/ja/orfoglipron-diabetes-obesity 2025-11-28T09:46:31.000Z daily 0.75 https://www.medxy.ai/news/zh/orforglipron-glp1-benefits 2025-11-28T09:46:39.000Z daily 0.75 https://www.medxy.ai/news/vi/tavi-hat-van-dong-mach 2025-11-28T09:46:48.000Z daily 0.75 https://www.medxy.ai/news/ja/tavi-for-aortic-regurgitation-2 2025-11-28T09:46:57.000Z daily 0.75 https://www.medxy.ai/news/tavi-for-aortic-regurgitation 2025-11-28T09:47:12.000Z daily 0.75 https://www.medxy.ai/news/pad4-nets-inflammasome-diabetes 2025-11-28T09:48:01.000Z daily 0.75 https://www.medxy.ai/news/vi/pad4-nets-inflammasome-diabetes-heart-kidney 2025-11-28T10:16:49.000Z daily 0.75 https://www.medxy.ai/news/ja/pad4-net-inflammasome-activation 2025-11-28T10:17:40.000Z daily 0.75 https://www.medxy.ai/news/zh/pad4-nets-inflammation-diabetes 2025-11-28T10:17:49.000Z daily 0.75 https://www.medxy.ai/news/trilogy-aortic-valve-safety-efficacy 2025-11-28T10:17:58.000Z daily 0.75 https://www.medxy.ai/news/vi/aortic-valve-safety-efficacy 2025-11-28T10:22:43.000Z daily 0.75 https://www.medxy.ai/news/ja/trilogy-aortic-valve-safety 2025-11-28T10:22:50.000Z daily 0.75 https://www.medxy.ai/news/cabg-vs-pci-women-cad 2025-11-28T10:21:53.000Z daily 0.75 https://www.medxy.ai/news/vi/cabg-vs-pci-women 2025-11-28T10:42:06.000Z daily 0.75 https://www.medxy.ai/news/zh/cabg-vs-pci-outcomes 2025-11-28T10:42:27.000Z daily 0.75 https://www.medxy.ai/news/vi/natural-channel-blocker-sodium 2025-11-28T10:52:58.000Z daily 0.75 https://www.medxy.ai/news/zh/sodium-channel-blocker 2025-11-28T10:52:53.000Z daily 0.75 https://www.medxy.ai/news/lipoprotein-a-dementia-link 2025-11-28T12:18:11.000Z daily 0.75 https://www.medxy.ai/news/vi/lipoprotein-a-dementia-risk 2025-11-28T12:38:34.000Z daily 0.75 https://www.medxy.ai/news/ja/apoa-and-dementia-risk 2025-11-28T12:38:23.000Z daily 0.75 https://www.medxy.ai/news/zh/lipoprotein-dementia-risk 2025-11-28T12:38:45.000Z daily 0.75 https://www.medxy.ai/news/mechanism-led-anoca-classification 2025-11-28T12:31:36.000Z daily 0.75 https://www.medxy.ai/news/vi/anoca-disorder-classification 2025-11-28T12:38:52.000Z daily 0.75 https://www.medxy.ai/news/ja/anoca-end-types 2025-11-28T12:38:58.000Z daily 0.75 https://www.medxy.ai/news/zh/mechanism-based-anoca-classification 2025-11-28T12:47:18.000Z daily 0.75 https://www.medxy.ai/news/aries-hm3-aspirin-lvad-2 2025-11-28T12:48:20.000Z daily 0.75 https://www.medxy.ai/news/vi/aries-hm3-aspirin-lvad 2025-11-28T12:49:01.000Z daily 0.75 https://www.medxy.ai/news/ja/aries-hm3-aspirin-summary 2025-11-28T12:49:11.000Z daily 0.75 https://www.medxy.ai/news/aspirin-healthy-elderly 2025-11-28T13:09:16.000Z daily 0.75 https://www.medxy.ai/news/vi/aspirin-for-healthy-elderly 2025-11-28T13:10:28.000Z daily 0.75 https://www.medxy.ai/news/ja/aspirin-in-healthy-elderly 2025-11-28T13:10:37.000Z daily 0.75 https://www.medxy.ai/news/zh/aspree-aspirin-risk 2025-11-28T13:10:44.000Z daily 0.75 https://www.medxy.ai/news/routine-coronary-testing-anoca 2025-11-28T14:48:48.000Z daily 0.75 https://www.medxy.ai/news/vi/functional-check-ano-ca 2025-11-28T14:48:35.000Z daily 0.75 https://www.medxy.ai/news/ja/improving-symptoms-anoca 2025-11-28T14:53:10.000Z daily 0.75 https://www.medxy.ai/news/zh/regular-coronary-function-testing-in-anoc 2025-11-28T14:48:59.000Z daily 0.75 https://www.medxy.ai/news/cryoballoon-vs-radiofrequency 2025-11-28T14:44:38.000Z daily 0.75 https://www.medxy.ai/news/vi/cold-cathode-heat-controls-afib 2025-11-28T14:53:21.000Z daily 0.75 https://www.medxy.ai/news/ja/cryoballoon-vs-radiofrequency-2 2025-11-28T14:54:22.000Z daily 0.75 https://www.medxy.ai/news/zh/cryoballoon-ablation-afib 2025-11-28T14:53:31.000Z daily 0.75 https://www.medxy.ai/news/high-sensitivity-troponins-dementia 2025-11-28T15:05:49.000Z daily 0.75 https://www.medxy.ai/news/vi/troponin-and-dementia-risk 2025-11-28T15:05:41.000Z daily 0.75 https://www.medxy.ai/news/ja/high-sensitivity-troponin-dementia-risk 2025-11-28T15:05:33.000Z daily 0.75 https://www.medxy.ai/news/zh/high-sensitivity-troponin-dementia-risk-2 2025-11-28T15:05:21.000Z daily 0.75 https://www.medxy.ai/news/empagliflozin-kidney-protection 2025-11-28T15:02:35.000Z daily 0.75 https://www.medxy.ai/news/vi/empagliflozin-kidney-protection-2 2025-11-28T15:06:35.000Z daily 0.75 https://www.medxy.ai/news/ja/emagliflozin-kidney-benefits 2025-11-28T17:39:40.000Z daily 0.75 https://www.medxy.ai/news/zh/entresto-kidney-protection 2025-11-28T17:39:56.000Z daily 0.75 https://www.medxy.ai/news/sglt2-inhibitors-protective 2025-11-28T17:40:50.000Z daily 0.75 https://www.medxy.ai/news/vi/sglt2-inhibitors-egrf-decline 2025-11-28T17:52:15.000Z daily 0.75 https://www.medxy.ai/news/ja/sglt2-inhibitors-efficacy 2025-11-28T17:52:34.000Z daily 0.75 https://www.medxy.ai/news/emperor-preserved-trial-review 2025-11-28T17:52:23.000Z daily 0.75 https://www.medxy.ai/news/vi/emperor-preserved-review 2025-11-28T17:52:58.000Z daily 0.75 https://www.medxy.ai/news/zh/sglt2-inhibitors-benefits-egrf-decline 2025-11-28T17:53:14.000Z daily 0.75 https://www.medxy.ai/news/ja/emperor-trial-review-emagliflozin 2025-11-28T17:53:30.000Z daily 0.75 https://www.medxy.ai/news/zh/emperor-trial-review 2025-11-28T17:54:14.000Z daily 0.75 https://www.medxy.ai/news/emperor-preserved-trial-review-2 2025-11-28T18:01:52.000Z daily 0.75 https://www.medxy.ai/news/vi/emperor-preserved-trial-review-3 2025-11-28T18:02:01.000Z daily 0.75 https://www.medxy.ai/news/ja/emperor-trial-review-3 2025-11-28T18:09:43.000Z daily 0.75 https://www.medxy.ai/news/zh/emperor-trial-review-2 2025-11-28T18:09:29.000Z daily 0.75 https://www.medxy.ai/news/gender-affirming-hormone-therapy-cardiovascular-events 2025-11-28T18:13:32.000Z daily 0.75 https://www.medxy.ai/news/genetic-liability-hypertension-risk 2025-11-28T18:30:44.000Z daily 0.75 https://www.medxy.ai/news/vi/hereditary-responsibility-hypertension-pregnancy 2025-11-28T18:30:30.000Z daily 0.75 https://www.medxy.ai/news/ja/gestational-hypertension-genetic-risk 2025-11-28T18:20:56.000Z daily 0.75 https://www.medxy.ai/news/zh/hypertension-genetics-cardiovascular-risk 2025-11-28T18:31:06.000Z daily 0.75 https://www.medxy.ai/news/better-carb-and-fiber 2025-11-28T18:29:38.000Z daily 0.75 https://www.medxy.ai/news/vi/high-quality-carb-powder-fiber 2025-11-28T18:30:54.000Z daily 0.75 https://www.medxy.ai/news/ja/high-quality-carbs-fiber-impact 2025-11-28T18:31:40.000Z daily 0.75 https://www.medxy.ai/news/zh/high-quality-carbs-healthy-heart 2025-11-28T19:04:44.000Z daily 0.75 https://www.medxy.ai/news/cumulative-atherogenic-exposure 2025-11-28T19:20:24.000Z daily 0.75 https://www.medxy.ai/news/vi/lipoprotein-a-and-cardiovascular-risk 2025-11-28T19:20:14.000Z daily 0.75 https://www.medxy.ai/news/ja/young-adult-atherosclerosis-risk 2025-11-28T19:20:10.000Z daily 0.75 https://www.medxy.ai/news/zh/young-adult-atherosclerosis-risk-2 2025-11-28T19:20:02.000Z daily 0.75 https://www.medxy.ai/news/vi/genetic-testing-early-afib 2025-11-28T19:39:11.000Z daily 0.75 https://www.medxy.ai/news/ja/early-onset-afib-gene-testing 2025-11-28T19:39:18.000Z daily 0.75 https://www.medxy.ai/news/zh/early-afib-genetic-testing 2025-11-28T19:39:25.000Z daily 0.75 https://www.medxy.ai/news/aetiology-guided-care-minoca 2025-11-29T09:04:45.000Z daily 0.75 https://www.medxy.ai/news/vi/cause-based-care-minoca 2025-11-29T09:27:43.000Z daily 0.75 https://www.medxy.ai/news/ja/minoca-treatment-improves-angina 2025-11-29T09:27:53.000Z daily 0.75 https://www.medxy.ai/news/zh/minoca-chest-pain-promise-findings 2025-11-29T09:27:59.000Z daily 0.75 https://www.medxy.ai/news/declining-kidney-function-hf-ref 2025-11-29T09:34:22.000Z daily 0.75 https://www.medxy.ai/news/vi/suy-than-hfref-egfr 2025-11-29T09:43:28.000Z daily 0.75 https://www.medxy.ai/news/ja/kidney-function-hfref-hospitalization 2025-11-29T09:36:44.000Z daily 0.75 https://www.medxy.ai/news/zh/decline-in-kidney-function-hfrefr-hospitalization 2025-11-29T09:42:37.000Z daily 0.75 https://www.medxy.ai/news/sudden-cardiac-arrest-risk-2 2025-11-29T09:40:47.000Z daily 0.75 https://www.medxy.ai/news/vi/sudden-cardiac-arrest-risk-3 2025-11-29T09:42:57.000Z daily 0.75 https://www.medxy.ai/news/ja/high-risk-sudden-cardiac-arrest-2 2025-11-29T10:01:44.000Z daily 0.75 https://www.medxy.ai/news/zh/high-risk-sudden-cardiac-arrest 2025-11-29T10:02:26.000Z daily 0.75 https://www.medxy.ai/news/caring-for-families-dilated-cardiomyopathy 2025-11-29T10:07:41.000Z daily 0.75 https://www.medxy.ai/news/zh/family-care-guidelines-expanded-cardiomyopathy 2025-11-29T10:07:33.000Z daily 0.75 https://www.medxy.ai/news/vi/family-care-hypertrophic-cardiomyopathy 2025-11-29T10:08:02.000Z daily 0.75 https://www.medxy.ai/news/ja/family-care-cardiomyopathy 2025-11-29T10:06:58.000Z daily 0.75 https://www.medxy.ai/news/high-throughput-patch-clamp 2025-11-29T10:09:47.000Z daily 0.75 https://www.medxy.ai/news/vi/high-throughput-scoring-scn5a 2025-11-29T12:15:22.000Z daily 0.75 https://www.medxy.ai/news/ja/high-throughput-patch-clamp-brugada 2025-11-29T12:15:36.000Z daily 0.75 https://www.medxy.ai/news/zh/high-throughput-scnaa-technique 2025-11-29T12:15:45.000Z daily 0.75 https://www.medxy.ai/news/anticoagulation-stroke-reduction-elderly 2025-11-29T12:16:40.000Z daily 0.75 https://www.medxy.ai/news/vi/widespread-anticoagulant-use 2025-11-29T12:21:04.000Z daily 0.75 https://www.medxy.ai/news/ja/anticoagulation-stroke-study 2025-11-29T12:23:55.000Z daily 0.75 https://www.medxy.ai/news/zh/extensive-anticoagulation-reduces-stroke 2025-11-29T12:28:22.000Z daily 0.75 https://www.medxy.ai/news/doacs-atrial-fibrillation-elderly 2025-11-29T12:32:37.000Z daily 0.75 https://www.medxy.ai/news/ja/doac-in-atrial-fibrillation 2025-11-29T12:36:15.000Z daily 0.75 https://www.medxy.ai/news/ja/doac-for-elderly-afib 2025-11-29T12:34:55.000Z daily 0.75 https://www.medxy.ai/news/oct-guided-stent-optimization 2025-11-29T12:37:09.000Z daily 0.75 https://www.medxy.ai/news/zh/direct-oral-anticoagulants-frail-afib 2025-11-29T12:52:56.000Z daily 0.75 https://www.medxy.ai/news/vi/oct-guided-stent-optimization-2 2025-11-29T12:53:03.000Z daily 0.75 https://www.medxy.ai/news/ja/oct-guided-stent-optimization-3 2025-11-29T12:53:15.000Z daily 0.75 https://www.medxy.ai/news/zh/oct-guided-stent-optimization-4 2025-11-29T12:53:22.000Z daily 0.75 https://www.medxy.ai/news/optical-coherence-tomography-coronary-stenting 2025-11-29T12:56:16.000Z daily 0.75 https://www.medxy.ai/news/vi/coronary-intervention-progress 2025-11-29T14:40:34.000Z daily 0.75 https://www.medxy.ai/news/ja/light-interferometry-coronary-stenting 2025-11-29T14:40:29.000Z daily 0.75 https://www.medxy.ai/news/zh/optical-coherence-cto-coronary-stenting 2025-11-29T14:40:22.000Z daily 0.75 https://www.medxy.ai/news/oct-guidance-cuts-mace 2025-11-29T14:43:18.000Z daily 0.75 https://www.medxy.ai/news/vi/oct-mace-reduction-pci 2025-11-29T17:26:08.000Z daily 0.75 https://www.medxy.ai/news/ja/oct-guide-pci-mace-reduction 2025-11-29T17:26:15.000Z daily 0.75 https://www.medxy.ai/news/zh/oct-guided-pci-outcomes 2025-11-29T17:26:20.000Z daily 0.75 https://www.medxy.ai/news/dual-pathology-aortic-stenosis 2025-11-29T17:47:42.000Z daily 0.75 https://www.medxy.ai/news/vi/tafamidis-avr-survival-amiloidosis 2025-11-29T17:48:28.000Z daily 0.75 https://www.medxy.ai/news/zh/tafamidis-avr-survival 2025-11-29T17:39:17.000Z daily 0.75 https://www.medxy.ai/news/smarca4-altered-nsclc 2025-11-29T17:43:58.000Z daily 0.75 https://www.medxy.ai/news/vi/nsclc-smarca4-mutant-immunotherapy 2025-11-29T17:44:48.000Z daily 0.75 https://www.medxy.ai/news/ja/smarca4-mutations-nsclc-immunotherapy 2025-11-29T17:48:50.000Z daily 0.75 https://www.medxy.ai/news/zh/smarca4-nsclc-treatment 2025-11-29T17:52:12.000Z daily 0.75 https://www.medxy.ai/news/surgical-vs-transcatheter-valve-footprint 2025-11-29T17:51:29.000Z daily 0.75 https://www.medxy.ai/news/vi/aortic-valve-surgery-carbon-footprint 2025-11-29T18:53:43.000Z daily 0.75 https://www.medxy.ai/news/ja/surgery-carbon-footprint 2025-11-29T18:53:53.000Z daily 0.75 https://www.medxy.ai/news/zh/aortic-valve-replacement-carbon-footprint 2025-11-29T18:54:03.000Z daily 0.75 https://www.medxy.ai/news/surgical-aortic-valve-replacement-co2 2025-11-29T18:54:47.000Z daily 0.75 https://www.medxy.ai/news/vi/aortic-valve-replacement-co2 2025-11-29T22:44:23.000Z daily 0.75 https://www.medxy.ai/news/ja/aortic-valve-replacement-co2-emissions 2025-11-29T22:44:33.000Z daily 0.75 https://www.medxy.ai/news/zh/aortic-valve-replacement-emissions 2025-11-29T22:44:42.000Z daily 0.75 https://www.medxy.ai/news/emat-cardiac-dysfunction 2025-11-29T19:21:38.000Z daily 0.75 https://www.medxy.ai/news/vi/emats-tim-disorder-screening 2025-11-29T22:45:15.000Z daily 0.75 https://www.medxy.ai/news/ja/emat-heart-failure 2025-11-29T22:45:25.000Z daily 0.75 https://www.medxy.ai/news/zh/emats-heart-function 2025-11-29T22:45:37.000Z daily 0.75 https://www.medxy.ai/news/high-viral-suppression-tld 2025-11-30T08:31:56.000Z daily 0.75 https://www.medxy.ai/news/vi/high-viral-suppression-tld-2 2025-11-29T22:45:46.000Z daily 0.75 https://www.medxy.ai/news/ja/pepfar-tld-viral-suppression-2 2025-11-29T22:45:56.000Z daily 0.75 https://www.medxy.ai/news/zh/pepfar-tld-viral-suppression 2025-11-29T22:46:04.000Z daily 0.75 https://www.medxy.ai/news/pembrolizumab-lenvatinib-mesothelioma 2025-11-29T22:43:51.000Z daily 0.75 https://www.medxy.ai/news/vi/pembrolizumab-lenvatinib-combination 2025-11-30T08:27:27.000Z daily 0.75 https://www.medxy.ai/news/ja/nivolumab-ipilimumab-thoracic-mesothelioma 2025-11-30T08:27:39.000Z daily 0.75 https://www.medxy.ai/news/zh/promising-results-pembrolizumab-therapy 2025-11-30T08:28:11.000Z daily 0.75 https://www.medxy.ai/news/microbubble-ultrasound-glioma 2025-11-29T22:51:58.000Z daily 0.75 https://www.medxy.ai/news/vi/urgent-care-research 2025-11-30T08:28:21.000Z daily 0.75 https://www.medxy.ai/news/ja/temozolomide-microbubble-ultrasound-study 2025-11-30T08:29:28.000Z daily 0.75 https://www.medxy.ai/news/zh/microbubble-ultrasound-glioma-treatment 2025-11-30T08:28:41.000Z daily 0.75 https://www.medxy.ai/news/rano-resection-classification-survival-gains 2025-11-29T23:15:31.000Z daily 0.75 https://www.medxy.ai/news/vi/rano-surgery-classification-idh-mutation 2025-11-30T08:28:52.000Z daily 0.75 https://www.medxy.ai/news/total-neoadjuvant-therapy-rectal-cancer 2025-11-29T23:23:13.000Z daily 0.75 https://www.medxy.ai/news/ja/standardized-rano-classification-survival-benefits 2025-11-30T08:29:58.000Z daily 0.75 https://www.medxy.ai/news/vi/preoperative-therapy-insights-2 2025-11-30T08:30:09.000Z daily 0.75 https://www.medxy.ai/news/zh/rano-classification-survival-benefit 2025-11-30T08:30:19.000Z daily 0.75 https://www.medxy.ai/news/ja/organ-sparing-cancer-treatment 2025-11-30T08:30:33.000Z daily 0.75 https://www.medxy.ai/news/zh/new-therapy-organ-preservation 2025-11-30T08:30:46.000Z daily 0.75 https://www.medxy.ai/news/camrelizumab-rivoceranib-survival-hcc 2025-11-30T08:30:56.000Z daily 0.75 https://www.medxy.ai/news/vi/camrelizumab-rivoceranib-hcc 2025-11-30T08:31:04.000Z daily 0.75 https://www.medxy.ai/news/ja/cambrelizumab-ribociclib-combo 2025-11-30T08:55:06.000Z daily 0.75 https://www.medxy.ai/news/zh/careli-antibody-apa-tinib-liver-cancer 2025-11-30T08:55:13.000Z daily 0.75 https://www.medxy.ai/news/disease-free-survival-breast-cancer 2025-11-30T08:55:21.000Z daily 0.75 https://www.medxy.ai/news/vi/survival-without-disease 2025-11-30T08:55:28.000Z daily 0.75 https://www.medxy.ai/news/ja/distant-disease-free-survival 2025-11-30T08:55:39.000Z daily 0.75 https://www.medxy.ai/news/zh/survival-indicator-breast-cancer 2025-11-30T08:55:49.000Z daily 0.75 https://www.medxy.ai/news/metronomic-capecitabine-dfs-benefit 2025-11-30T08:50:31.000Z daily 0.75 https://www.medxy.ai/news/vi/capecitabine-low-dose-benefits 2025-11-30T08:55:57.000Z daily 0.75 https://www.medxy.ai/news/ja/metro-nomic-capecitabine-triple-negative-breast-cancer 2025-11-30T09:06:35.000Z daily 0.75 https://www.medxy.ai/news/zh/capecitabine-in-triple-negative-breast-cancer 2025-11-30T09:20:44.000Z daily 0.75 https://www.medxy.ai/news/high-cardiovascular-risk-apls 2025-11-30T09:06:57.000Z daily 0.75 https://www.medxy.ai/news/vi/high-cardiovascular-risk-aps 2025-11-30T09:20:28.000Z daily 0.75 https://www.medxy.ai/news/ja/antiphospholipid-syndrome-risks 2025-11-30T09:20:15.000Z daily 0.75 https://www.medxy.ai/news/zh/antiphospholipid-syndrome-cardiovascular-risk 2025-11-30T09:20:02.000Z daily 0.75 https://www.medxy.ai/news/mirikizumab-ulcerative-colitis 2025-11-30T09:19:54.000Z daily 0.75 https://www.medxy.ai/news/vi/mirikizumab-colitis-trial-results 2025-11-30T09:23:12.000Z daily 0.75 https://www.medxy.ai/news/ja/mirikizumab-ulcerative-colitis-results 2025-11-30T09:30:51.000Z daily 0.75 https://www.medxy.ai/news/zh/mirikizumab-ulcerative-colitis-2 2025-11-30T09:30:29.000Z daily 0.75 https://www.medxy.ai/news/vi/fuzuloparib-apatinib-breast-cancer 2025-11-30T18:20:17.000Z daily 0.75 https://www.medxy.ai/news/ja/fuzuloparib-apatinib-gbrca-breast-cancer 2025-11-30T18:20:24.000Z daily 0.75 https://www.medxy.ai/news/zh/fluzaoparib-apatinib-pfs 2025-11-30T18:20:30.000Z daily 0.75 https://www.medxy.ai/news/eutcv-vicrm197-non-inferior 2025-11-30T11:42:49.000Z daily 0.75 https://www.medxy.ai/news/vi/eutcv-vicrm197-comparison-kenya-senegal 2025-11-30T18:20:44.000Z daily 0.75 https://www.medxy.ai/news/ja/kenya-senegal-eutcv-vicrm197 2025-11-30T18:21:03.000Z daily 0.75 https://www.medxy.ai/news/zh/eutcv-vs-typhbar 2025-11-30T18:21:31.000Z daily 0.75 https://www.medxy.ai/news/hiv-care-engagement-vn 2025-11-30T18:21:22.000Z daily 0.75 https://www.medxy.ai/news/vi/hiv-care-engagement-evaluation 2025-11-30T18:21:40.000Z daily 0.75 https://www.medxy.ai/news/ja/hiv-care-navigation-vietnam 2025-11-30T18:21:51.000Z daily 0.75 https://www.medxy.ai/news/zh/hiv-care-engagement-vietnam 2025-11-30T18:22:02.000Z daily 0.75 https://www.medxy.ai/news/preoperative-anaemia-common 2025-11-30T11:58:37.000Z daily 0.75 https://www.medxy.ai/news/vi/preoperative-anemia-factors-2 2025-11-30T18:22:17.000Z daily 0.75 https://www.medxy.ai/news/ja/preoperative-anemia-factors-3 2025-11-30T18:22:31.000Z daily 0.75 https://www.medxy.ai/news/zh/preoperative-anemia-factors 2025-11-30T18:22:41.000Z daily 0.75 https://www.medxy.ai/news/cyclic-cushings-syndrome 2025-11-30T13:20:22.000Z daily 0.75 https://www.medxy.ai/news/vi/cushing-syndrome-challenges 2025-11-30T18:22:46.000Z daily 0.75 https://www.medxy.ai/news/zh/cushing-syndrome-strategies 2025-11-30T18:23:04.000Z daily 0.75 https://www.medxy.ai/news/normalising-renin-aldosteronism 2025-11-30T17:58:45.000Z daily 0.75 https://www.medxy.ai/news/vi/renin-normalization-cardiovascular-risk 2025-11-30T18:24:22.000Z daily 0.75 https://www.medxy.ai/news/ja/aldosterone-treatment-renin-normalization 2025-11-30T18:23:21.000Z daily 0.75 https://www.medxy.ai/news/zh/renal-normalization-aldo 2025-11-30T18:23:31.000Z daily 0.75 https://www.medxy.ai/news/large-phase-3-trials-iclepertin-cognitive-benefit 2025-11-30T18:25:35.000Z daily 0.75 https://www.medxy.ai/news/vi/three-phase-trial-iclerpertin 2025-11-30T18:32:43.000Z daily 0.75 https://www.medxy.ai/news/sex-specific-ageing-paths-china 2025-12-01T08:11:21.000Z daily 0.75 https://www.medxy.ai/news/vi/gender-approaches-aging-china 2025-12-01T11:40:18.000Z daily 0.75 https://www.medxy.ai/news/ja/gender-discrimination-aging-path 2025-12-01T11:40:31.000Z daily 0.75 https://www.medxy.ai/news/zh/gender-specific-paths-independent-living 2025-12-01T11:40:37.000Z daily 0.75 https://www.medxy.ai/news/clozapine-transdiagnostic-effectiveness 2025-12-01T10:57:02.000Z daily 0.75 https://www.medxy.ai/news/vi/clozapine-effectiveness-schizophrenia 2025-12-01T11:40:49.000Z daily 0.75 https://www.medxy.ai/news/ja/clozapine-effectiveness-safety 2025-12-01T11:40:56.000Z daily 0.75 https://www.medxy.ai/news/zh/clozapine-uses-beyond-schizophrenia 2025-12-01T11:41:27.000Z daily 0.75 https://www.medxy.ai/news/full-milk-feeds-late-preterm 2025-12-01T11:17:47.000Z daily 0.75 https://www.medxy.ai/news/vi/full-dairy-intake-in-infants 2025-12-01T11:41:37.000Z daily 0.75 https://www.medxy.ai/news/ja/complete-milk-intake-premature 2025-12-01T11:41:43.000Z daily 0.75 https://www.medxy.ai/news/zh/exclusive-breastfeeding-premature-infants 2025-12-01T11:41:50.000Z daily 0.75 https://www.medxy.ai/news/deep-learning-sjogrens-disease 2025-12-01T11:26:32.000Z daily 0.75 https://www.medxy.ai/news/vi/deep-learning-sjogrens-classification 2025-12-01T11:42:01.000Z daily 0.75 https://www.medxy.ai/news/ja/deep-learning-sjogren-classification-2 2025-12-01T11:42:10.000Z daily 0.75 https://www.medxy.ai/news/zh/deep-learning-sjogren-classification 2025-12-01T11:42:22.000Z daily 0.75 https://www.medxy.ai/news/dupilumab-vs-omalizumab 2025-12-01T11:36:49.000Z daily 0.75 https://www.medxy.ai/news/vi/dupilumab-vs-omalizumab-2 2025-12-01T11:42:56.000Z daily 0.75 https://www.medxy.ai/news/ja/dupilumab-vs-omalizumab-4 2025-12-01T11:46:35.000Z daily 0.75 https://www.medxy.ai/news/zh/dupilumab-vs-omalizumab-3 2025-12-01T11:46:22.000Z daily 0.75 https://www.medxy.ai/news/checkpoint-inhibition-sclc 2025-12-01T11:52:26.000Z daily 0.75 https://www.medxy.ai/news/vi/checkpoint-inhibitor-sclc-patients 2025-12-01T12:59:10.000Z daily 0.75 https://www.medxy.ai/news/ja/checkpoint-inhibition-in-weak-patients 2025-12-01T12:58:57.000Z daily 0.75 https://www.medxy.ai/news/zh/immune-checkpoint-inhibitors-insufficient-patients 2025-12-01T12:59:39.000Z daily 0.75 https://www.medxy.ai/news/respiratory-drive-outcomes 2025-12-01T12:47:49.000Z daily 0.75 https://www.medxy.ai/news/vi/too-little-too-much-breathing-effort 2025-12-01T13:00:07.000Z daily 0.75 https://www.medxy.ai/news/ja/breath-effort-ventilation-outcomes 2025-12-01T13:00:22.000Z daily 0.75 https://www.medxy.ai/news/zh/mechanical-ventilation-outcomes 2025-12-01T13:00:31.000Z daily 0.75 https://www.medxy.ai/news/allopurinol-risk-model 2025-12-01T13:01:04.000Z daily 0.75 https://www.medxy.ai/news/vi/allopurinol-skin-reaction-prediction 2025-12-01T16:16:40.000Z daily 0.75 https://www.medxy.ai/news/ja/allopurinol-skin-reaction-risk 2025-12-01T16:16:55.000Z daily 0.75 https://www.medxy.ai/news/zh/allopurinol-skin-reaction-model 2025-12-01T16:18:16.000Z daily 0.75 https://www.medxy.ai/news/novel-poliovirus-vaccines 2025-12-01T13:26:35.000Z daily 0.75 https://www.medxy.ai/news/ja/safety-immunogenicity-opv 2025-12-01T16:19:22.000Z daily 0.75 https://www.medxy.ai/news/zh/new-oral-polio-vaccine-safety 2025-12-01T16:19:52.000Z daily 0.75 https://www.medxy.ai/news/real-world-brivaracetam-benefits 2025-12-01T16:10:27.000Z daily 0.75 https://www.medxy.ai/news/vi/brivaracetam-in-epilepsy 2025-12-01T16:20:55.000Z daily 0.75 https://www.medxy.ai/news/ja/brivaracetam-benefits 2025-12-01T16:21:16.000Z daily 0.75 https://www.medxy.ai/news/zh/burosumab-in-epilepsy 2025-12-01T16:21:30.000Z daily 0.75